Humana Inc (HUM)

Humana Announces Agreement to Divest Minority Interest in GentivaJune 10, 2026 4:30 PM
Business Wire Humana Inc. (NYSE: HUM) today announced that it has signed a definitive agreement with a consortium of investors to divest all or substantially all of its minority interest in Gentiva, the nation’s leading provider of end-of-life services, including hospice and palliative care. The agreement values Humana’s minority interest stake at approximately $900 million. Other financial terms were not disclosed. Humana intends to utilize proceeds from the sale for general corporate purposes. The transaction is expected to close in the third quarter of 2026, subject to regulatory approvals and other customary closing conditions, and the company does not anticipate a material impact to 2026 earnings from this pending transaction. Humana’s ownership interest in Gentiva resulted from its earlier acquisition of the remaining interest in Kindred at Home (KAH) in 2021. At that time, Humana indicated its intent to ultimately divest non-core KAH businesses, including hospice, palliative, and personal health care services. In 2022, Humana announced an agreement to divest a majority interest in the Hospice and Personal Care divisions of Humana’s Kindred at Home subsidiary (KAH Hospice) to private investment firm Clayton, Dubilier & Rice (CD&R). These divisions were then subsequently restructured into a standalone business and rebranded to Gentiva, which is now the nation’s largest end-of-life care provider, with thousands of compassionate clinicians and caregivers providing services at more than 430 locations in 35 states. Guggenheim Securities, LLC is acting as financial advisor to Humana. Fried, Frank, Harris, Shriver & Jacobson LLP and Manatt, Phelps & Phillips LLP are acting as legal advisors to Humana. About Humana Humana is a leading U.S. healthcare company. Through our Humana insurance services, and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com. More information regarding Humana is available to investors via the Investor Relations page of the company’s website at humana.com, including copies of: Annual reports to stockholders Securities and Exchange Commission filings Most recent investor conference presentations Quarterly earnings news releases and conference calls Calendar of events Corporate Governance information Cautionary Statement This news release includes forward-looking statements regarding Humana within the meaning of the Private Securities Litigation Reform Act of 1995. When used in investor documents, press releases, filings with the Securities and Exchange Commission, and in oral statements made with the approval of an authorized executive officer, the words or phrases like “expects,” “believes,” “anticipates,” “intends,” “likely will result,” “estimates,” “projects” or variations of such words and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions, including, among other things, information set forth in the “Risk Factors” section of Humana’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the SEC. In making these statements, Humana is not undertaking to address or update each forward-looking statement in future filings or communications regarding its business or results, and is not undertaking to address how any of these factors may have caused results to differ from discussions or information contained in previous filings or communications. In light of these risks, uncertainties, and assumptions, the forward-looking events discussed herein might not occur. There also may be other risks that Humana is unable to predict at this time. Any of these risks and uncertainties may cause Humana’s actual results to differ materially from the results discussed in the forward-looking statements. Humana cautions investors against relying on forward-looking statements as they are subject to numerous risks and uncertainties that may change at any time. Humana undertakes no obligation to publicly revise or update these forward-looking statements, whether as a result of new information, future events, or otherwise. View source version on businesswire.com: https://www.businesswire.com/news/home/20260610493628/en/ Investors: Lisa Stoner - Humana Investor Relations; (502) 580-2652; lstamper@humana.com
Media: Mark Taylor - Humana Corporate Communications; (317) 753-0345; MTaylor108@humana.com Original: Humana Announces Agreement to Divest Minority Interest in Gentiva

Humana, CenterWell and USAA Unite with VFW for National Day of Service Supporting Veterans Experiencing HomelessnessMay 14, 2026 8:23 AM
Business Wire Collaborative service projects in Tampa, San Antonio and Nashville highlight shared commitment to veterans’ health, dignity and well-being Humana Inc. and the Veterans of Foreign Wars (VFW), in collaboration with CenterWell, USAA and Volunteers of America (VOA), will bring together employees, veteran advocates and community partners on May 19 to support veterans experiencing homelessness. As part of the VFW’s annual Day of Service, volunteers will unite in three different locations — Nashville, Tennessee; San Antonio, Texas; and Tampa, Florida — for hands-on service projects that deliver tangible support to veterans and seniors in need. Collectively, volunteers at the three locations will prepare 4,000 essential care kits to be distributed through trusted community partners. “Veterans deserve more than our gratitude. They deserve action, partnership and sustained support,” said Cara Brown, Director of Key Relationships at Humana. “By joining forces in communities across the country, we’re creating meaningful opportunities for our employees and partners to serve with purpose while delivering real, measurable impact for veterans in need.” Three Cities, One Mission The Day of Service events, taking place at local CenterWell Senior Primary Care and Conviva Senior Primary Care centers, will include: Nashville, Tennessee: Volunteers will assemble 2,000 care kits in support of Volunteers of America’s street outreach efforts, helping individuals experiencing homelessness connect with person-centered case management, resource navigation and material support. San Antonio, Texas: Volunteers will pack 1,000 toiletry kits for seniors, supporting dignity and daily health needs in a community with one of the nation’s largest veteran populations. Tampa, Florida: Volunteers will prepare 1,000 toiletry kits for local veterans experiencing housing insecurity, in partnership with community organizations serving the region’s growing veteran population. “Our Day of Service projects reflect the heart of the VFW’s mission — veterans helping veterans,” said VFW National Commander Carol Whitmore. “Our relationship with Humana, USAA and CenterWell demonstrates what’s possible when organizations come together with shared values of honor, service and community to ensure no veteran is forgotten.” Building Toward a National Impact Moment This year’s collaboration marks a new partnership with Volunteers of America, ensuring service efforts are aligned with real-time community needs and are reaching veterans and seniors most at risk. Together, the organizations aim to create momentum throughout the year — engaging local markets nationwide, strengthening relationships with local VFW Posts and its Auxiliaries, and inspiring continued involvement beyond a single day of service. “Our goal is not just a day of volunteering, but a sustained commitment,” Brown added. “By working alongside VFW Posts, veteran advocates and organizations like Volunteers of America, we’re helping build healthier futures for those who have served — today and for years to come.” The 2026 Day of Service builds on the VFW’s growing national movement of service. Since launching the Day of Service in 2022 as an extension of the VFW’s Still Serving campaign, participation has expanded dramatically. In 2025 alone, more than 2,300 service events were held across the United States and internationally, underscoring the power of community-driven action. About Humana Humana (NYSE: HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we strive to make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com. About the VFW The Veterans of Foreign Wars of the U.S. is the nation's largest and most established major war veterans organization. Founded in 1899, the congressionally chartered VFW is comprised entirely of eligible veterans and military service members from the active, Guard and Reserve forces. With more than 1.43 million VFW and Auxiliary members located in nearly 6,000 Posts worldwide, the nonprofit veterans service organization is proud to proclaim “NO ONE DOES MORE FOR VETERANS” than the VFW, which is dedicated to veterans’ service, legislative advocacy, and military and community service programs. For more information or to join, visit our website at vfw.org. View source version on businesswire.com: https://www.businesswire.com/news/home/20260514257755/en/ Kelli LeGaspi
Humana Corporate Communications
e-mail: klegaspi1@humana.com Original: Humana, CenterWell and USAA Unite with VFW for National Day of Service Supporting Veterans Experiencing Homelessness

Humana Invests More Than $1 Million to Advance Health Outcomes Across LouisianaMay 13, 2026 9:29 AM
Business Wire Grants will support statewide priorities essential to improving population health Humana’s Medicaid managed care plan, Healthy Horizons in Louisiana, has committed more than $1 million in strategic investments to expand access to care, address chronic disease, and strengthen behavioral and maternal health supports across Louisiana. By partnering with trusted organizations that understand the needs of their communities, Humana is furthering its commitment to support the priorities set by the Louisiana Department of Health. “Louisiana families deserve opportunities for better health—no matter where they live,” said Michelle Alletto, President, Humana Healthy Horizons in Louisiana. “These investments reflect our commitment to driving transformational change for all Louisianans.” This year’s investments support organizations advancing quality outcomes, access to care, chronic disease prevention, behavioral health, workforce development, and maternal and child health priorities. Funding will help deliver mobile health services, expand diabetes and cancer prevention programs, support trauma-informed youth initiatives, and strengthen local health workforce pathways. 2026 grant recipients include: Allegiance Health: Supports a mobile health initiative delivering preventive, primary, and chronic care services, including screenings for blood pressure, vision, glucose, depression, and maternal wellness. Events will be held across Louisiana in both urban and rural areas. American Diabetes Association: Expands Project Power Youth, serving 500 children ages 5–12 with nutrition education, physical activity programming, and family engagement—aimed at slowing childhood obesity and preventing type 2 diabetes in high-risk communities. Community Foundation of North Louisiana (Step Forward Initiative): Helps children and families affected by poverty through resilience-building programs including teen suicide prevention, workforce readiness, and youth mental health education across region 7. NOELA Community Health Center: Targets outreach and health screenings for multiple diseases, including cervical cancer and breast cancer, in New Orleans East. Second Harvest Food Bank of Greater New Orleans and Acadiana: Supports the Makin’ Groceries Mobile Market, which brings fresh, affordable food to 23 parishes, and provides education around healthful nutritional choices. Xavier University of Louisiana: Strengthens workforce development pathways through scholarships for students in the physician assistant program. Through these strategic investments and partnerships, Humana Healthy Horizons is helping advance the state’s priority of improving health outcomes for all residents. By supporting local organizations and innovative programs, Humana remains committed to expanding access and fostering progress toward a healthier Louisiana. About Humana Humana (NYSE:HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20260513612130/en/ Angie Weiss
Humana Corporate Communications
aweiss3@humana.com Original: Humana Invests More Than $1 Million to Advance Health Outcomes Across Louisiana

Humana Shares Slide Despite Q1 Earnings BeatApril 29, 2026 7:09 AM
IH Market News
Humana Inc. (NYSE:HUM) reported first-quarter results on Wednesday that exceeded earnings expectations, but its shares dropped 5.1% following the release.Adjusted earnings per share came in at $10.31, ahead of the analyst consensus of $10.20. The result landed at the upper end of the company’s guidance range, representing roughly 110% to 115% of its full-year 2026 adjusted EPS outlook.Humana reaffirmed its full-year 2026 adjusted EPS guidance of at least $9.00, which remains above the analyst consensus of $8.71. However, the midpoint of the outlook implies a year-over-year decline, reflecting pressure from Star Ratings for the 2026 bonus year. The company also lowered its GAAP EPS guidance to at least $8.36, down from its previous estimate of at least $8.89.Within its Insurance segment, the GAAP benefit ratio came in at 89.4%, slightly better than management’s expectation of just under 90%. The company maintained its full-year 2026 guidance for the Insurance segment benefit ratio at 92.75%, plus or minus 25 basis points. It also reaffirmed expected growth of approximately 25% in individual Medicare Advantage membership compared with 2025, supported by new customer additions and improved retention.“We’ve had a solid start to the year and feel good about how our operating execution and transformation initiatives are setting us up for the future,” said Jim Rechtin. “We continue to make progress where it counts for customers – quality experience and outstanding care.”The company reported sequential growth of 110,500 patients, or more than 22%, in its CenterWell Senior Primary Care business, including around 59,000 patients and 54 centers added through the recent acquisition of MaxHealth.Membership in state-based contracts increased by about 50,000 during the quarter, driven by new program launches in Michigan, Illinois, and South Carolina.Humana also announced that George Renaudin, President of the Insurance segment, will retire effective June 29, 2026, with Aaron Martin set to take over the role.Humana stock price

Original: Humana Shares Slide Despite Q1 Earnings Beat

Humana Reports First Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial GuidanceApril 29, 2026 6:00 AM
Business Wire

Reports 1Q26 earnings per share (EPS) of $9.83 on a GAAP basis, Adjusted EPS of $10.31; at the high end of the company's guidance of approximately 110 percent to 115 percent of full year (FY) 2026 Adjusted EPS



1Q26 Insurance segment GAAP benefit ratio of 89.4 percent, slightly favorable to management's guidance of 'just under 90 percent'; affirms FY 2026 Insurance segment benefit ratio guidance of 92.75 percent, plus or minus 25 basis points



Affirms Adjusted FY 2026 GAAP EPS guidance of 'at least $9.00'; while revising GAAP EPS guidance to 'at least $8.36' from the previous estimate of 'at least $8.89'



Affirms FY 2026 individual Medicare Advantage (MA) membership growth of 'approximately 25 percent' over 2025; driven by new sales and improved retention from the company's customer-led benefit strategy and changes to its customer service approach



Continued execution of strategic growth initiatives and integration of new contracts within CenterWell and state-based contracts businesses, respectively, to expand the company's national footprint


Sequential growth of 110,500 patients, or over 22 percent, in CenterWell Senior Primary Care, including approximately 59,000 patients and 54 centers associated with the recently completed acquisition of MaxHealth



CenterWell Pharmacy and Cost Plus partnering to develop new, end-to-end employer prescription drug solutions



1Q26 state-based contracts membership growth of approximately 50,000, driven by the start of programs in Michigan, Illinois, and South Carolina






Publishes prepared management remarks to Investor Relations page of www.humana.com ahead of this morning's 8:00 a.m. ET question and answer session to discuss its financial results for the quarter and expectations for future earnings



Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended March 31, 2026 (1Q26) versus the quarter ended March 31, 2025 (1Q25) as noted in the tables below.




Consolidated income before income taxes and equity in net losses (pretax results)




in millions






1Q26 (a)






1Q25 (a)








Generally Accepted Accounting Principles (GAAP)






$1,595






 






$1,691








Amortization associated with identifiable intangibles






11






 






15








Put/call valuation adjustments associated with company's non-consolidating minority interest investments






(34






)






163








Value creation initiatives






98






 






24








Adjusted (non-GAAP)






$1,670






 






$1,893









Diluted earnings per share (EPS)






1Q26 (a)






1Q25 (a)








GAAP






$9.83






 






$10.30






 








Amortization associated with identifiable intangibles






0.09






 






0.12






 








Put/call valuation adjustments associated with company's non-consolidating minority interest investments






(0.28






)






1.35






 








Value creation initiatives






0.81






 






0.20






 








Tax impact of non-GAAP adjustments






(0.14






)






(0.39






)








Adjusted (non-GAAP)






$10.31






 






$11.58






 








Refer to the "Footnotes" section included herein for further explanation of disclosures for Adjusted (non-GAAP) financial measures, as well as reconciliations.







Please refer to the tables above, as well as the consolidated and segment highlight sections in the detailed earnings release for additional discussion of the factors impacting the year-over-year comparisons.


“We’ve had a solid start to the year and feel good about how our operating execution and transformation initiatives are setting us up for the future,” said Humana President and CEO Jim Rechtin. “We continue to make progress where it counts for customers - quality experience and outstanding care.”


Insurance Leadership Transition Update (Announced December 2025)


The company today confirmed that George Renaudin, Insurance Segment President, will retire effective June 29, 2026, consistent with the timeline previously communicated. Until that date, Renaudin will focus primarily on the annual Medicare Advantage bid process, while Aaron Martin, currently President of Medicare Advantage, will begin leading the day-to-day management of the Insurance Segment. Upon Renaudin’s retirement, Martin will formally assume the role of Insurance Segment President and Renaudin will serve as a strategic advisor to the company through at least the end of 2026. The company also confirmed that 30-year industry veteran John Barger will begin leading Medicare Advantage operations effective immediately and will formally assume the role of President of Medicare Advantage upon Renaudin’s retirement.


FY 2026 Earnings Guidance


Humana revises its GAAP EPS guidance for the year ending December 31, 2026 (FY 2026) to 'at least $8.36' from 'at least $8.89', while affirming its Adjusted EPS guidance of 'at least $9.00'. The FY 2026 Adjusted EPS guidance anticipates a year-over-year decline as a result of the Star Ratings headwind for Bonus Year (BY) 2026, net of mitigation.




 




Diluted earnings per share (a)






FY 2026




Guidance






FY 2025








GAAP






at least $8.36






$9.84






 








Amortization associated with identifiable intangibles






0.30






 






0.42






 








Put/call valuation adjustments associated with the company's non-consolidating minority interest investments (b)






(0.28






)






4.25






 








Value creation initiatives (b)






0.81






 






3.72






 








Impact of exit of employer group commercial medical products business (b)






—






 






(0.52






)








Settlement of certain litigation expenses (b)






—






 






0.13






 








Loss on sale of business (b)






—






 






0.55






 








Impairment charges (b)






—






 






2.09






 








Cumulative net tax impact






(0.19






)






(3.34






)








Adjusted (non-GAAP) – FY 2026 projected (b); FY 2025 reported






at least $9.00






$17.14






 








Refer to the "Footnotes" section included herein for further explanation of disclosures for Adjusted (non-GAAP) financial measures, as well as additional reconciliations.







Detailed Press Release


Humana’s full earnings press release, including the statistical pages, has been posted to the company’s Investor Relations site and may be accessed at https://humana.gcs-web.com/ or via a current report on Form 8-K filed by the company with the Securities and Exchange Commission this morning (available at www.sec.gov or on the company’s website).


Conference Call


Humana will host a live question-and-answer session for analysts at 8:00 a.m. Eastern time today to discuss its financial results for the quarter and the company’s expectations for future earnings. In advance of the question-and-answer session, Humana will post prepared management remarks to the Quarterly Results section of its Investor Relations page (https://humana.gcs-web.com/financial-information/quarterly-results).


A webcast of the 1Q26 earnings call may be accessed via Humana’s Investor Relations page at https://humana.gcs-web.com/.


If you anticipate asking a question during the question-and-answer session, please register in advance at this link - https://register-conf.media-server.com/register/BId1413c4c078343e28841e18c372f7b58.


Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique registrant ID.


The company suggests participants listening via the web or the conference call sign in or dial in at least 15 minutes in advance of the call. For those unable to participate in the live event, the virtual presentation archive will be available in the Historical Webcasts and Presentations section of the Investor Relations page at https://humana.gcs-web.com/, approximately two hours following the live webcast.


Footnotes


The company has included financial measures throughout this earnings release that are not in accordance with GAAP. Management believes that these measures, when presented in conjunction with the corresponding GAAP measures, provide a comprehensive perspective to more accurately compare and analyze the company’s core operating performance over time. Consequently, management uses these non-GAAP (Adjusted) financial measures as consistent indicators of the company’s core business operations from period to period, as well as for planning and decision-making purposes and in determination of incentive compensation. Non-GAAP (Adjusted) financial measures should be considered in addition to, but not as a substitute for, or superior to, financial measures prepared in accordance with GAAP. The company’s non-GAAP measures are not intended to normalize earnings, eliminate volatility, or represent future performance. Non-GAAP measures are subject to inherent limitations and may differ from similarly titled measures used by other companies. All financial measures in this earnings release are in accordance with GAAP unless otherwise indicated. Please refer to the footnotes for a detailed description of each item adjusted out of GAAP financial measures to arrive at non-GAAP (Adjusted) financial measures.


(a) For the periods covered in this earnings release, the following items are excluded from the non-GAAP financial measures described above, as applicable.



Amortization associated with identifiable intangibles - Since amortization varies based on the size and timing of acquisition activity, management believes the exclusion of this non-cash expense provides a more consistent and uniform indicator of performance from period to period. For all periods shown within this earnings release, GAAP measures affected include consolidated pretax results, EPS, and Insurance and CenterWell segments' income from operations. The table below discloses respective period amortization expense for each segment:





Amortization




(in millions)






1Q26






1Q25








Insurance segment






$4






$4








CenterWell segment






$7






$11








Put/call valuation adjustments associated with the company’s non-consolidating minority interest investments - These non-cash amounts are the result of fair value measurements associated with the company's primary care strategic partnership and are unrelated to the company's core business performance. For all periods shown within this earnings release, GAAP measures affected include consolidated pretax results and EPS.




Value creation initiatives - These charges relate to the company's multi-year transformation program, as approved by management with defined scope and milestones. The intent of the program is to re-align the company’s cost structure, operating model, and technology footprint with evolving market conditions. These costs primarily include severance and associate exit costs, asset impairments, and external consulting expenses incurred to execute the program. These charges were recorded at the corporate level and not allocated to the segments. The company has consistently applied this adjustment across all periods. For all periods shown within this earnings release, GAAP measures affected in this release include consolidated pretax results, EPS, and the consolidated operating cost ratio.




Cumulative net tax impact - This adjustment represents the cumulative net impact of the corresponding tax benefit or expense at the applicable marginal rate related to the aforementioned items excluded from the applicable GAAP measures. For FY 2025, the tax adjustment reflects the impact of the loss on sale of business, which exceeded the book loss. The related tax benefit from the loss on sale of business is realizable via capital loss carryback. The tax impact of the aforementioned items differs from the statutory rates due to jurisdictional mix, limitations on deductibility, and other factors. The cumulative tax impact is not intended to represent a normalized effective tax rate or expected future tax outcomes. For all periods presented in this earnings release, EPS is the sole GAAP measure affected.



The following adjustments impact only the FY 2025 GAAP EPS shown within this release on page 2.



Impact of exit of employer group commercial medical products business - These amounts relate to activity from the exit of the employer group commercial medical products business as announced by Humana on February 23, 2023.




Settlement of certain litigation expenses - These charges relate to expenses the company recognized in connection with a discrete legal matter. The nature and magnitude of this settlement are not indicative of the company’s ongoing operations.




Loss on sale of business - This discrete disposition is not part of the company's ordinary course operations and the impacts recognized from the disposal do not reflect core operational performance. The loss primarily reflects the difference between the carrying value and proceeds at the time of sale.




Impairment charges - The company recognized non-cash impairment charges related to certain indefinite-lived intangible assets based on the company's estimate of future financial performance in certain state markets. Additionally, the company recognized non-cash impairment charges in the fourth quarter of 2025 related to a discrete joint-venture investment for which the company held minority ownership interests that were deemed to be unrecoverable based on recent market activity. These charges were recorded at the corporate level and not allocated to the segments.



In addition to the reconciliations shown on page 2 of this release, the following are reconciliations of GAAP to Adjusted (non-GAAP) measures described above and disclosed within this earnings release:


Operating cost ratio




CONSOLIDATED




Operating cost ratio






1Q26






 






1Q25






 








GAAP






10.2






%






10.6






%








Value creation initiatives






(0.2






)%






(0.1






)%








Adjusted (non-GAAP)






10.0






%






10.5






%







Insurance Segment - Income from operations




INSURANCE SEGMENT




Income from operations




(in millions)






1Q26






1Q25








GAAP






$1,435






$1,574








Amortization associated with identifiable intangibles






4






4








Adjusted (non-GAAP)






$1,439






$1,578







(b) FY 2026 GAAP EPS guidance and FY 2026 Adjusted (non-GAAP) EPS guidance exclude the impact of future value changes to items that have not yet been recognized and cannot currently be reasonably estimated at this time.


Cautionary Statement


This news release includes forward-looking statements regarding Humana within the meaning of the Private Securities Litigation Reform Act of 1995. When used in investor presentations, press releases, Securities and Exchange Commission (SEC) filings, and in oral statements made by or with the approval of one of Humana’s executive officers, the words or phrases like “expects,” “believes,” “anticipates,” “assumes,” “intends,” “likely will result,” “estimates,” “projects” or variations of such words and similar expressions are intended to identify such forward-looking statements.


These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions, including, among other things, information set forth in the “Risk Factors” section of the company’s SEC filings, a summary of which includes but is not limited to the following:



If Humana does not design and price its products properly and competitively, if the premiums Humana receives are insufficient to cover the cost of healthcare services delivered to its members, if the company is unable to implement clinical initiatives to provide a better healthcare experience for its members, lower costs and appropriately document the risk profile of its members, or if its estimates of benefits expense are inadequate, Humana’s profitability could be materially adversely affected. Humana estimates the costs of its benefit expense payments, and designs and prices its products accordingly, using actuarial methods and assumptions based upon, among other relevant factors, claim payment patterns, medical cost inflation, and historical developments such as claim inventory levels and claim receipt patterns. The company continually reviews estimates of future payments relating to benefit expenses for services incurred in the current and prior periods and makes necessary adjustments to its reserves, including premium deficiency reserves, where appropriate. These estimates involve extensive judgment, and have considerable inherent variability because they are extremely sensitive to changes in claim payment patterns and medical cost trends. Accordingly, Humana's reserves may be insufficient.




If Humana fails to effectively implement its operational and strategic initiatives, including its Medicare initiatives, which are of particular importance given the concentration of the company's revenues in these products, state-based contract strategy, the growth of its CenterWell business, and its integrated care delivery model, the company’s business may be materially adversely affected.




The number of Humana’s Medicare Advantage plans rated 4-star or higher significantly declined in 2025. Humana filed a lawsuit seeking to set aside and vacate the 2025 Star Ratings of its Medicare Advantage plans, and on October 14, 2025, the Court issued a decision rejecting Humana's challenge. Although the company has appealed that decision, there can be no assurances that it will ultimately prevail in the lawsuit. If the company is not successful, the decline in Star Ratings will negatively impact its 2026 quality bonus payments from CMS and may also significantly adversely affect the company’s revenues, operating results, and cash flows. In addition, there can be no assurances the company will be successful in maintaining or improving its Star Ratings in future years.




If Humana, or the third-party service providers on which it relies, fails to properly maintain the integrity of its data, to strategically maintain existing or implement new information systems (including systems powered by or incorporating artificial intelligence (AI) or machine learning (ML)), or to protect Humana’s proprietary rights to its systems, or to defend against cyber-security attacks, contain such attacks when they occur, or prevent other privacy or data security incidents that result in security breaches that disrupt the company's operations or in the unintentional dissemination of sensitive personal information or proprietary or confidential information, the company’s business may be materially adversely affected.




Humana is involved in various legal actions, or disputes that could lead to legal actions (such as, among other things, provider contract disputes and qui tam litigation brought by individuals on behalf of the government), governmental and internal investigations, and routine internal review of business processes any of which, if resolved unfavorably to the company, could result in substantial monetary damages or changes in its business practices. Increased litigation and negative publicity could also increase the company’s cost of doing business.




As a government contractor, Humana is exposed to risks that may materially adversely affect its business or its willingness or ability to participate in government healthcare programs including, among other things, loss of material government contracts; governmental audits and investigations; potential inadequacy of government determined payment rates; potential restrictions on profitability, including by comparison of profitability of the company’s Medicare Advantage business to non-Medicare Advantage business; or other changes in the governmental programs in which Humana participates. Changes to the risk-adjustment model utilized by CMS to adjust premiums paid to Medicare Advantage plans or retrospective recovery by CMS of previously paid premiums as a result of the final rule related to the risk adjustment data validation audit methodology published by CMS on January 30, 2023 (Final RADV Rule), which Humana believes fails to address adequately the statutory requirement of actuarial equivalence and violates the Administrative Procedure Act due to its failure to include a "Fee for Service Adjuster" could have a material adverse effect on the company's operating results, financial position and cash flows.




Humana's business activities are subject to substantial government regulation. New laws or regulations, or legislative, judicial, or regulatory changes in existing laws or regulations or their manner of application could increase the company's cost of doing business and have a material adverse effect on Humana’s results of operations (including restricting revenue, enrollment and premium growth in certain products and market segments, restricting the company’s ability to expand into new markets, increasing the company’s medical and operating costs by, among other things, requiring a minimum benefit ratio on insured products, lowering the company’s Medicare payment rates and increasing the company’s expenses associated with a non-deductible health insurance industry fee and other assessments); the company’s financial position (including the company’s ability to maintain the value of its goodwill); and the company’s cash flows.




Humana’s failure to manage acquisitions, divestitures and other significant transactions successfully may have a material adverse effect on the company’s results of operations, financial position, and cash flows.




If Humana fails to develop and maintain satisfactory relationships with the providers of care to its members, the company’s business may be adversely affected.




Humana faces significant competition in attracting and retaining talented employees. Further, managing succession for, and retention of, key executives is critical to the Company’s success, and its failure to do so could adversely affect the Company’s businesses, operating results and/or future performance.




Humana’s pharmacy business is highly competitive and subjects it to regulations and supply chain risks in addition to those the company faces with its core health benefits businesses.




Changes in the prescription drug industry pricing benchmarks may adversely affect Humana’s financial performance.




Humana’s ability to obtain funds from certain of its licensed subsidiaries is restricted by state insurance regulations.




Downgrades in Humana’s debt ratings, should they occur, may adversely affect its business, results of operations, and financial condition.




Volatility or disruption in the securities and credit markets may significantly and adversely affect the value of our investment portfolio and the investment income that we derive from this portfolio.



In making forward-looking statements, Humana is not undertaking to address or update them in future filings or communications regarding its business or results. In light of these risks, uncertainties, and assumptions, the forward-looking events discussed herein may or may not occur. There also may be other risks that the company is unable to predict at this time. Any of these risks and uncertainties may cause actual results to differ materially from the results discussed in the forward-looking statements.


Humana advises investors to read the following documents as filed by the company with the SEC for further discussion both of the risks it faces and its historical performance:



Form 10-K for the year ended December 31, 2025; and




Form 8-Ks filed during 2026.



About Humana


Humana (NYSE: HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com. 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260429489812/en/
Lisa Stoner

Humana Investor Relations

(502) 580-2652

e-mail: LStamper@humana.com


Mark Taylor

Humana Corporate Communications

(317) 753-0345

e-mail: MTaylor108@humana.com


Original: Humana Reports First Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance

Humana Board Declares Payment of Quarterly Dividend to StockholdersApril 15, 2026 5:00 PM
Business Wire
Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on July 31, 2026 to stockholders of record as of the close of business on June 26, 2026.


About Humana


Humana (NYSE: HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260415863102/en/
FOR MORE INFORMATION CONTACT:


Lisa Stoner

Humana Investor Relations

(502) 580-2652

e-mail: lstamper@humana.com


Mark Taylor

Humana Corporate Communications

(317) 753-0345

e-mail: Mtaylor108@humana.com


Original: Humana Board Declares Payment of Quarterly Dividend to Stockholders

Tuesday Health Expands National Footprint With Humana Partnership to Advance Value-Based Palliative CareApril 14, 2026 9:19 AM
PR Newswire (US)

Program launching June 1, 2026 will expand access to community-based palliative care for members living with serious illnessHOUSTON, April 14, 2026 /PRNewswire/ -- Tuesday Health today announced a new partnership with Humana Inc. (NYSE: HUM) to expand access to value-based palliative care for Texans living with serious illness, marking another step in the company's growing national footprint. Launching June 1, the program will support eligible Humana members and their caregivers with coordinated clinical guidance, proactive symptom management and ongoing support designed to improve quality of life and help members receive care aligned with their individual goals.







Through the partnership, eligible Humana members will gain access to Tuesday Health's interdisciplinary care teams, including nurses, social workers, nurse practitioners and physicians. Working alongside members' existing clinicians, these teams help manage symptoms, guide complex medical decisions and support caregivers throughout the serious illness journey. Care is delivered through a flexible model that includes in-person and virtual visits, with 24/7 clinical access to ensure support is available when it matters most in members' places of comfort."Living with serious illness can be overwhelming for members and their families, at any stage of their journey," said Dr. Traci Granston, Vice President, Trend and Clinical Innovation at Humana. "Through our partnership with Tuesday Health, we're expanding access to palliative care that is not limited to end-of-life care but can be provided alongside curative treatment—offering coordinated, whole-person support that helps manage symptoms, improve quality of life and ensure care is aligned with what matters most to each individual."According to the Center to Advance Palliative Care, nationwide there are more than 12 million Americans currently live with serious illness, a number expected to grow significantly as the population ages. As health plans look for new ways to support members with complex needs, value-based palliative care models are emerging as an essential part of delivering better care experiences, stronger caregiver support and more coordinated care."Our mission is to ensure people living with serious illness, and the caregivers who support them, never feel like they are navigating this journey alone," said Jim Wieland, CEO of Tuesday Health. "As we continue expanding our care model nationwide, partnerships like this allow us to bring proactive, relationship-based support to more members, improving quality of life and helping avoid unnecessary hospital visits."This partnership represents another milestone in Tuesday Health's continued national expansion as health plans increasingly seek scalable solutions for serious illness care. Tuesday Health partners with national and regional health plans across all lines of business to deliver coordinated palliative care that improves quality of life while helping reduce avoidable hospital and emergency department visits.About Tuesday HealthTuesday Health is a value-based palliative care provider group dedicated to transforming serious illness and end-of-life care. We deliver goal-centered care focused on alleviating physical symptoms and emotional stress for individuals and their caregivers. Our interdisciplinary care teams reduce avoidable hospitalizations and improve quality of life wherever individuals call home. Through our leading-edge care model, Tuesday Health is shaping the future of community-based palliative care nationwide.Media ContactLauren Jones
Communications, Tuesday Health
lauren.jones @Nathan Carney-6825



View original content to download multimedia:https://www.prnewswire.com/news-releases/tuesday-health-expands-national-footprint-with-humana-partnership-to-advance-value-based-palliative-care-302741430.htmlSOURCE Tuesday Health

Original: Tuesday Health Expands National Footprint With Humana Partnership to Advance Value-Based Palliative Care

Humana Elects Robert S. Field to Board of DirectorsApril 10, 2026 4:30 PM
Business Wire

Field is the Principal and Managing Member of ?Med Capital Management LLC, an investment firm focused on U.S. healthcare services companies, primarily in the managed care industry.



Humana Inc. (NYSE: HUM) announced today that Robert S. Field has been elected as a member of the Company’s Board of Directors, effective immediately following the Company’s 2026 Annual Meeting of Stockholders.


Field is the Principal and Managing Member of ?Med Capital Management LLC, an investment firm focused on U.S. healthcare services companies, primarily in the managed care industry. He previously served as a senior analyst at Luxor Capital, a multi-strategy investment fund, where he led healthcare services investments. Earlier in his career, Field worked as an associate at McKinsey & Company, focused on corporate and business strategy and previously practiced antitrust law at Vinson & Elkins LLP.


“We are pleased to welcome Rob and are confident that the investor perspective he has developed over more than two decades as a healthcare investor will bring meaningful insight to our Board,” said Humana Chairman of the Board Kurt J. Hilzinger. “His deep expertise across investment evaluation, risk oversight, and capital allocation —along with his strong understanding of legal and regulatory dynamics in the healthcare sector — will be valuable as Humana executes on its strategy to drive profitable, sustainable growth and long-term shareholder value.”


Field’s appointment follows a comprehensive search process led by the Humana Board and informed by shareholder engagement, including helpful input from John Petry, Managing Member of Sessa Capital, as part of the Company’s ongoing commitment to Board refreshment and strong corporate governance.


About Humana


Humana is a leading U.S. healthcare company. Through our Humana insurance services, and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260410859088/en/
Investors:

Lisa Stoner - Humana Investor Relations; (502) 580-2652;

lstamper@humana.com


Media:

Mark Taylor - Humana Corporate Communications; (317) 753-0345;

MTaylor108@humana.com


Original: Humana Elects Robert S. Field to Board of Directors

Humana Goes Live with b.well to Deliver on Health Data Interoperability CommitmentsApril 9, 2026 6:00 AM
Business Wire
Humana and b.well are delivering on a shared commitment to improve individual access to health data and reduce administrative waste in the healthcare system.


Humana Inc. announced today it has gone live with b.well Connected Health, fulfilling a shared commitment to simplifying how individuals access, understand, and use their health data.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260409894576/en/
Through the relationship, Humana will leverage b.well’s national health data network to enable individuals to securely connect and access their health data across multiple providers, health plans, pharmacies, and digital health applications — all in one place. Additionally, Humana will be able to access its members’ data in real-time at the point of claims processing and securely respond to data requests from providers and other health plans, supporting industry use cases such as care coordination and quality improvement.


This collaboration supports Humana’s pledge to the CMS Health Technology Ecosystem, and advances a more connected, interoperable healthcare system – one where individuals can access and share their data without friction, payers can automate critical workflows, and providers have timely access to the data needed to deliver high-quality care.


“Humana is taking a meaningful step toward making healthcare simpler and more connected for its members,” said Kristen Valdes, CEO of b.well Connected Health. “Through our national health data network and network-of-networks approach, we’re enabling access to the most complete, semantically normalized longitudinal health record. When members can securely access and use their data across sources, it opens the door to more informed decisions, better care coordination, and experiences that truly reflect the needs of the individual.”


At the core of the collaboration is b.well’s national health data network spanning connections to 2.4 million providers, 350 health plans, labs, wearables, and more, and a 13-step data refinery process, which normalizes, deduplicates, and enriches fragmented data into a complete longitudinal health record. This foundation enables real-time insights, supports clinical workflows, reduces administrative waste, and powers more personalized, data-driven experiences for Humana members.


“Humana is focused on making healthcare simpler and more connected for our members,” said Caraline Coats, Senior Vice President of Provider Strategy and Operations at Humana. “We appreciate CMS’ leadership in advancing the Health Technology Ecosystem and creating a clear framework to support that goal. Through our work with b.well, we’re improving access to health information which, in turn, helps free up time and resources so providers can focus on delivering care.”


Why This Matters


This collaboration delivers measurable value across the healthcare system by:



Putting individuals in control of their health data. Individuals have the ability to securely access, manage, and share their health data, consistent with broader industry goals of improving data portability, transparency and patient empowerment.



Reducing administrative burden through easier data sharing. Standards-based, digital data exchange reduces reliance on manual processes, duplicative documentation, and fragmented record requests, helping to lower administrative costs and inefficiencies across the healthcare system.



Supporting Interoperability and Data Access Efforts


The collaboration aligns with ongoing efforts across the healthcare system to give individuals greater control over their health data and access to digital tools that improve care experiences.


Humana and b.well are participating in a capability demonstration at the U.S. Department of Health and Human Services (HHS) today, showcasing live, standards-based data in a federal interoperability demonstration setting.


By participating in interoperability initiatives, Humana is helping advance a future where healthcare data is accessible, actionable, and patient-directed, reducing administrative burden while improving outcomes for individuals.


About Humana


Humana (NYSE: HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we strive to make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.


About b.well Connected Health


b.well Connected Health is the most connected digital health platform for AI-powered consumer experiences, personalized care, and better outcomes. The company is solving healthcare’s fragmentation problem with a scalable, FHIR-based platform that unifies health data, solutions, and services in one place, empowering organizations to offer consumers personalized, actionable experiences. By creating longitudinal health records, delivering proactive insights, and simplifying access to care, b.well enables better outcomes at lower cost while supporting regulatory compliance. Learn more at www.bwell.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260409894576/en/
FOR MORE INFORMATION CONTACT:


Kelli LeGaspi

Humana Corporate Communications

e-mail: klegaspi1@humana.com


Patty Keiler

b.well Media Relations

Patty@collaborate.health


Original: Humana Goes Live with b.well to Deliver on Health Data Interoperability Commitments

CORRECTING and REPLACING Humana Releases 2025 Impact Report, Highlighting Progress Towards Simpler, More Affordable Care for People and CommunitiesApril 6, 2026 2:37 PM
Business Wire
Report outlines advancements in whole-person health, community partnerships, and environmental stewardship


Please replace the release with the following corrected version due to multiple revisions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260406534123/en/
The updated release reads:


HUMANA RELEASES 2025 IMPACT REPORT, HIGHLIGHTING PROGRESS TOWARDS SIMPLER, MORE AFFORDABLE CARE FOR PEOPLE AND COMMUNITIES


Report outlines advancements in whole-person health, community partnerships, and environmental stewardship


Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, today released its 2025 Humana Impact Report, detailing the company’s progress in making healthcare simpler more affordable and more connected for the people and communities it serves.


“Humana is making care easier to navigate, more affordable to access and more responsive to what people need,” said Jim Rechtin, Humana President and Chief Executive Officer. “The latest Impact Report shows that when we listen closely to the needs of our customers, we can do more to help our members and patients achieve their best health, while strengthening our communities.”


Centered on four pillars -- supporting each person, advancing the healthcare system, strengthening communities, and caring for the environment—the report details Humana’s efforts to simplify, strengthen community connections, and deliver measurable outcomes.


2025 Humana Impact Report: Key Highlights



Simplified and strengthened affordable coverage for nearly 8 million Medicare Advantage and prescription drug plan members, including standardized plan options, $0 copays for preventive care, primary care visits and many Tier 1 prescriptions.



Strengthened communities nationwide through Humana Community Day, touching 1.6 million lives through service projects and supporting 600 nonprofit organizations.



Expanded access to care for more than 1.48 million Medicaid members, completing 905, 500+ social determinants of health screenings to help identify and address barriers to care.



Improved healthcare quality and outcomes, including 24.3% fewer inpatient admissions and 13.4% fewer emergency department visits for Medicare Advantage members in value-based care models.



Enhanced workforce engagement, with 78% of employees saying they feel they belong at Humana, reinforcing a culture that enables teams to deliver for members and patients.



Reduced environmental impact, including a 38% reduction in Humana’s vehicle fleet footprint, and a 93% waste diversion rate for furniture and fixtures.



Impact at a Glance



Nearly 8 million Medicare Advantage and prescription drug plan members supported



1.48 million Medicaid members served, with 905,500+ social determinants of health screenings completed



2.46 million stand-alone prescription drug plan (PDP) members supported with affordable medication access, including 854,200 LI NET enrollments enabling real-time pharmacy coverage for low-income seniors



1.6 million lives touched through Humana Community Day efforts



Nearly 196,900 people accessed Humana Community Navigator® to find free or reduced-cost community resources such as food, housing and transportation assistance



Nearly 80% of CenterWell Home Health providers earned 4-star or higher quality ratings



78% of employees say they feel they belong at Humana, reinforcing a strong, connected workforce



38% reduction in vehicle fleet footprint and 93% waste diversion rate for furniture and fixtures



Read the full 2025 Humana Impact Report to learn more about Humana’s progress on affordability, access to care, community impact, and environmental stewardship.


About Humana


Humana (NYSE:HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260406534123/en/
FOR MORE INFORMATION, CONTACT:

Sara Nelson

Humana Corporate Communications

snelson31@humana.com


Original: CORRECTING and REPLACING Humana Releases 2025 Impact Report, Highlighting Progress Towards Simpler, More Affordable Care for People and Communities

Humana Inc. to Release First Quarter 2026 Results on April 29, 2026March 30, 2026 4:30 PM
Business Wire
Humana Inc. (NYSE: HUM) will release its financial results for the first quarter 2026 (1Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on April 29, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026.


A webcast of the 1Q26 earnings call may be accessed via Humana’s Investor Relations page at https://humana.gcs-web.com/.


If you anticipate asking a question during the question-and-answer session, please register in advance using this link, https://register-conf.media-server.com/register/BId1413c4c078343e28841e18c372f7b58.


Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique registrant ID.


The company suggests participants listening via the web or the conference call sign in or dial in at least 15 minutes in advance of the call. For those unable to participate in the live event, the virtual presentation archive will be available in the Historical Webcasts and Presentations section of the Investor Relations page at https://humana.gcs-web.com/, approximately two hours following the live webcast.


The company’s 1Q26 earnings news release is expected to include financial measures that are not in accordance with Generally Accepted Accounting Principles (GAAP). A reconciliation of non-GAAP financial measures to financial results under GAAP, as well as management’s reasons for including non-GAAP financial measures, will be included in the company’s 1Q26 earnings news release, a copy of which will be available on the Investor Relations page of www.humana.com on April 29, 2026.


About Humana


Humana (NYSE: HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260330483762/en/
FOR MORE INFORMATION CONTACT:


Lisa Stoner

Humana Investor Relations

(502) 580-2652

e-mail: lstamper@humana.com


Mark Taylor

Humana Corporate Communications

(317) 753-0345

e-mail: mtaylor108@humana.com


Original: Humana Inc. to Release First Quarter 2026 Results on April 29, 2026

Continuous Glucose Monitoring on the Rise Among Medicare Advantage Members with Type 2 DiabetesMarch 12, 2026 9:30 AM
Business Wire
Study by Humana Healthcare Research and Yale School of Medicine researcher reveals significant increase in CGM usage, particularly among older adults with chronic health conditions.


A new study published in the current issue of the Journal of Managed Care & Specialty Pharmacy (JMCP)—conducted by a Humana Healthcare Research team and Dr. Joseph S. Ross of the Yale School of Medicine—reveals a notable increase in the use of continuous glucose monitors (CGMs) among Medicare Advantage members with type 2 diabetes from 2021 to 2023.


The study also compared the demographic and clinical characteristics of members with type 2 diabetes who used CGMs with those who did not in 2023, finding that the CGM users often had more complex health problems than those who did not.


CGMs represent a major advancement over traditional fingerstick glucose monitoring methods, providing real-time, continuous blood glucose data that supports more effective management of dangerous highs and lows and reduces the burden of daily monitoring. Yet, clinicians still have incomplete information about which patients use these devices and what barriers may exist for those not currently using them.


As one of the first studies to examine CGM use in this population, it underscores the need for further research to understand clinical outcomes and to identify which patients benefit most as access expands.


Additional key findings include:



The proportion of Medicare Advantage members with type 2 diabetes who use insulin and continuous glucose monitors increased from fewer than 2 in 100 in January 2021 to about 1 in 6 by December 2023.



The growth in adoption of CGMs was concurrent with the expansion of Medicare coverage for the devices in 2023.



In the 2023 study group, patients who had an endocrinology visit during the year were more than four times as likely to use a CGM device.



The analysis found that patients with fewer interactions with the health care system, as well as those in the oldest age group, were less likely to use CGMs.



“This research is significant because, until now, there has been limited information about the use of continuous glucose monitors among Medicare Advantage members—a population in which diabetes and the management of multiple health conditions are common,” said Dr. Mark Mugavin, Medical Director at Humana. “These insights help us identify which patients may benefit most from CGMs, including those who do not visit the doctor frequently, and guide our strategies for reaching and supporting those who need them most. Ultimately, this work enables us to improve health outcomes by ensuring that more members receive timely and effective diabetes management tools.”


“CGMs are an important new technology to assist patients in managing their diabetes,” said Dr. Ross. “Characterizing trends in uptake and use helps us better understand the impact of Medicare coverage decisions on new technology adoption and allows us to identify which patient populations may not be achieving the same access to this new technology as others.”


In 2026, most individuals with a Humana Medicare Advantage plan can obtain a CGM at no out-of-pocket cost, as these devices will be fully covered by their plan.


You can access the full study on the JMCP website found here.


About Humana Healthcare Research


Humana Healthcare Research is a team of expert researchers dedicated to transforming healthcare through impactful, data-driven insights. As a subsidiary of Humana, Humana Healthcare Research collaborates with leading academic and industry partners to advance and shape innovation in care delivery and health policy for better outcomes.


About Humana


Humana (NYSE:HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260312636561/en/
Media Contact

Lisa Dimond

Humana Corporate Communications

832-330-4702

ldimond@humana.com


Original: Continuous Glucose Monitoring on the Rise Among Medicare Advantage Members with Type 2 Diabetes

Humana Completes Aggregate $1.0 Billion Fixed-to-Fixed Rate Junior Subordinated Notes OfferingMarch 9, 2026 5:00 PM
Business Wire
Humana Inc. (the “company”) (NYSE: HUM) announced today the completion of its public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056, at 6.625 percent of the principal amount (the “Junior Subordinated Notes Offering”).


The company expects net proceeds from the Junior Subordinated Notes Offering will be approximately $986 million after deducting underwriters’ discounts and estimated offering expenses. The company intends to use the net proceeds from the Junior Subordinated Notes Offering for general corporate purposes, which may include the repayment of existing indebtedness, including borrowings under its commercial paper program.


Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC acted as active joint book-running managers for the Junior Subordinated Notes Offering.


The Junior Subordinated Notes Offering was made pursuant to an effective shelf registration statement (including a base prospectus) filed with the Securities and Exchange Commission (the “SEC”). The Junior Subordinated Notes Offering was made by means of a prospectus and related prospectus supplement, copies of which may be obtained by contacting Goldman Sachs & Co. LLC toll-free at +1-866-471-2526; J.P. Morgan Securities LLC by email at prospectus-eq_fi@jpmchase.com or postsalemanualrequests @FILTHYLUCRE-271-7403; Truist Securities, Inc toll-free at +1-800-685-4786; or Wells Fargo Securities, LLC toll-free at +1-800-645-3751. An electronic copy of the registration statement and prospectus supplement, together with the base prospectus, is available on the SEC’s website at www.sec.gov.


This news release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.


Cautionary Statement


This news release includes forward-looking statements regarding Humana within the meaning of the Private Securities Litigation Reform Act of 1995. When used in investor presentations, press releases, SEC filings, and in oral statements made by or with the approval of one of Humana’s executive officers, the words or phrases like “expects,” “believes,” “anticipates,” “assumes,” “intends,” “likely will result,” “estimates,” “projects” or variations of such words and similar expressions are intended to identify such forward-looking statements.


These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions, including, among other things, information set forth in the “Risk Factors” section of the company’s SEC filings, a summary of which includes but is not limited to the following:



If Humana does not design and price its products properly and competitively, if the premiums Humana receives are insufficient to cover the cost of healthcare services delivered to its members, if the company is unable to implement clinical initiatives to provide a better healthcare experience for its members, lower costs and appropriately document the risk profile of its members, or if its estimates of benefits expense are inadequate, Humana’s profitability could be materially adversely affected. Humana estimates the costs of its benefit expense payments, and designs and prices its products accordingly, using actuarial methods and assumptions based upon, among other relevant factors, claim payment patterns, medical cost inflation, and historical developments such as claim inventory levels and claim receipt patterns. The company continually reviews estimates of future payments relating to benefit expenses for services incurred in the current and prior periods and makes necessary adjustments to its reserves, including premium deficiency reserves, where appropriate. These estimates involve extensive judgment, and have considerable inherent variability because they are extremely sensitive to changes in claim payment patterns and medical cost trends. Accordingly, Humana’s reserves may be insufficient.



If Humana fails to effectively implement its operational and strategic initiatives, including its Medicare initiatives, which are of particular importance given the concentration of the company’s revenues in these products, state-based contract strategy, the growth of its CenterWell business, and its integrated care delivery model, the company’s business may be materially adversely affected.



The number of Humana’s Medicare Advantage plans rated 4-star or higher significantly declined in 2025. Humana filed a lawsuit seeking to set aside and vacate the 2025 Star Ratings of its Medicare Advantage plans, and on October 14, 2025, the Court issued a decision rejecting Humana’s challenge. Although the company has appealed that decision, there can be no assurances that it will ultimately prevail in the lawsuit. If the company is not successful, the decline in Star Ratings will negatively impact its 2026 quality bonus payments from Centers for Medicare and Medicaid Services (“CMS”) and may also significantly adversely affect the company’s revenues, operating results, and cash flows. In addition, there can be no assurances the company will be successful in maintaining or improving its Star Ratings in future years.



If Humana, or the third-party service providers on which it relies, fails to properly maintain the integrity of its data, to strategically maintain existing or implement new information systems (including systems powered by or incorporating artificial intelligence (AI) or machine learning (ML)), or to protect Humana’s proprietary rights to its systems, or to defend against cyber-security attacks, contain such attacks when they occur, or prevent other privacy or data security incidents that result in security breaches that disrupt the company’s operations or in the unintentional dissemination of sensitive personal information or proprietary or confidential information, the company’s business may be materially adversely affected.



Humana is involved in various legal actions, or disputes that could lead to legal actions (such as, among other things, provider contract disputes and qui tam litigation brought by individuals on behalf of the government), governmental and internal investigations, and routine internal review of business processes any of which, if resolved unfavorably to the company, could result in substantial monetary damages or changes in its business practices. Increased litigation and negative publicity could also increase the company’s cost of doing business.



As a government contractor, Humana is exposed to risks that may materially adversely affect its business or its willingness or ability to participate in government healthcare programs including, among other things, loss of material government contracts; governmental audits and investigations; potential inadequacy of government determined payment rates; potential restrictions on profitability, including by comparison of profitability of the company’s Medicare Advantage business to non-Medicare Advantage business; or other changes in the governmental programs in which Humana participates. Changes to the risk-adjustment model utilized by CMS to adjust premiums paid to Medicare Advantage plans or retrospective recovery by CMS of previously paid premiums as a result of the final rule related to the risk adjustment data validation audit methodology published by CMS on January 30, 2023 (Final RADV Rule), which Humana believes fails to address adequately the statutory requirement of actuarial equivalence and violates the Administrative Procedure Act due to its failure to include a “Fee for Service Adjuster” could have a material adverse effect on the company’s operating results, financial position and cash flows.



Humana’s business activities are subject to substantial government regulation. New laws or regulations, or legislative, judicial, or regulatory changes in existing laws or regulations or their manner of application could increase the company’s cost of doing business and have a material adverse effect on Humana’s results of operations (including restricting revenue, enrollment and premium growth in certain products and market segments, restricting the company’s ability to expand into new markets, increasing the company’s medical and operating costs by, among other things, requiring a minimum benefit ratio on insured products, lowering the company’s Medicare payment rates and increasing the company’s expenses associated with a non-deductible health insurance industry fee and other assessments); the company’s financial position (including the company’s ability to maintain the value of its goodwill); and the company’s cash flows.



Humana’s failure to manage acquisitions, divestitures and other significant transactions successfully may have a material adverse effect on the company’s results of operations, financial position, and cash flows.



If Humana fails to develop and maintain satisfactory relationships with the providers of care to its members, the company’s business may be adversely affected.



Humana faces significant competition in attracting and retaining talented employees. Further, managing succession for, and retention of, key executives is critical to the company’s success, and its failure to do so could adversely affect the company’s businesses, operating results and/or future performance.



Humana’s pharmacy business is highly competitive and subjects it to regulations and supply chain risks in addition to those the company faces with its core health benefits businesses.



Changes in the prescription drug industry pricing benchmarks may adversely affect Humana’s financial performance.



Humana’s ability to obtain funds from certain of its licensed subsidiaries is restricted by state insurance regulations.



Downgrades in Humana’s debt ratings, should they occur, may adversely affect its business, results of operations, and financial condition.



Volatility or disruption in the securities and credit markets may significantly and adversely affect the value of Humana’s investment portfolio and the investment income that Humana derives from this portfolio.



In making forward-looking statements, Humana is not undertaking to address or update them in future filings or communications regarding its business or results. In light of these risks, uncertainties, and assumptions, the forward-looking events discussed herein may or may not occur. There also may be other risks that the company is unable to predict at this time. Any of these risks and uncertainties may cause actual results to differ materially from the results discussed in the forward-looking statements.


Humana advises investors to read the Form 10-K for the year ended December 31, 2025 as filed by the company with the SEC for further discussion both of the risks it faces and its historical performance.


About Humana


Humana Inc. is a leading U.S. healthcare company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260309041509/en/
Lisa Stoner

Humana Investor Relations

502-580-2652

e-mail: lstamper@humana.com


Mark Taylor

Humana Corporate Communications

317-753-0345

e-mail: mtaylor108@humana.com


Original: Humana Completes Aggregate $1.0 Billion Fixed-to-Fixed Rate Junior Subordinated Notes Offering

AM Best Assigns Issue Credit Rating to Humana Inc.’s New Junior Subordinated NotesMarch 6, 2026 11:04 AM
Business Wire
AM Best has assigned a Long-Term Issue Credit Rating of “bbb-” (Good) to the $1 billion, 6.625% fixed rate junior subordinated notes, due 2056, of Humana Inc. (Humana) (headquartered in Louisville, KY) [NYSE: HUM]. The outlook assigned to this Credit Rating (rating) is stable. All other ratings of Humana and its subsidiaries remain unchanged.


Humana expects to use the proceeds from the junior subordinated notes issuance for general corporate purposes, which may include repayment of existing indebtedness, including borrowings under its commercial paper program. AM Best expects the issuance to increase financial leverage slightly in the intermediate term. The company’s financial leverage, as measured by AM Best, will increase slightly from year-end 2025 to approximately 41.8% with the new issuance. Financial leverage has exceeded the organization's long-term target debt-to-capital ratio of 40%, but management expects to manage to this target through increases in equity and continued deleveraging over the course of the year.


Humana’s earnings before interest and taxes (EBIT) interest coverage remains solid at 4-8 times in recent years; however, it has dropped off from the double-digit range a few years ago due to a decline in operating results, driven by increased utilization and changes in reimbursement in its Medicare Advantage segment in the last few years, as well as higher interest expenses.


Humana has sound liquidity measures as the organization generates consistently strong operating cash flows; however, cash flow in 2025 totaled $0.9 billion, a notable decrease from $3 billion in 2024. This was driven by timing impacts, the increase in receivables due to the Inflation Reduction Act and the unfavorable impact of working capital items. Liquidity is also supported by dividends primarily from subsidiaries, which totaled $1.1 billion for 2025, as well as its lines of credit totaling $5 billion, as well as its $5 billion commercial paper program and access to short-term borrowings from the Federal Home Loan Bank of Cincinnati through its subsidiary, Humana Insurance Company.


The organization’s consistent-yet-declining profitability has driven equity growth over the past five-year period. Humana again generated strong premium growth in 2025, driven by its core Medicare Advantage segment, but premium revenue is also generated from its Medicaid managed care and supplementary lines. Although profitability increased in 2025, net income was impacted by increased utilization in Medicare Advantage. AM Best expects the company’s earnings to remain positive albeit with margin compression throughout 2026.


This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments.


AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.


Copyright © 2026 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260306918327/en/
James Quito

Financial Analyst

+1 908 882 2460

james.quito@ambest.com
Joseph Zazzera

Director

+1 908 882 2442

joseph.zazzera@ambest.com
Christopher Sharkey

Associate Director, Public Relations

+1 908 882 2310

christopher.sharkey@ambest.com
Al Slavin

Senior Public Relations Specialist

+1 908 882 2318

al.slavin@ambest.com


Original: AM Best Assigns Issue Credit Rating to Humana Inc.’s New Junior Subordinated Notes

Humana Prices $1.0 Billion Fixed-to-Fixed Rate Junior Subordinated Notes OfferingMarch 5, 2026 7:08 PM
Business Wire
Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056, at 100.000 percent of the principal amount (the “Junior Subordinated Notes Offering”). The Junior Subordinated Notes Offering is expected to close on March 9, 2026, subject to the satisfaction of customary closing conditions.


The company expects net proceeds from the Junior Subordinated Notes Offering will be approximately $986 million after deducting underwriters’ discounts and estimated offering expenses. The company intends to use the net proceeds from the Junior Subordinated Notes Offering for general corporate purposes, which may include the repayment of existing indebtedness, including borrowings under its commercial paper program.


Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC are acting as active joint book-running managers for the Junior Subordinated Notes Offering.


The Junior Subordinated Notes Offering is being made pursuant to an effective shelf registration statement (including a base prospectus) filed with the Securities and Exchange Commission (the “SEC”). The Junior Subordinated Notes Offering may be made only by means of a prospectus and related prospectus supplement, copies of which may be obtained by contacting Goldman Sachs & Co. LLC toll-free at +1-866-471-2526; J.P. Morgan Securities LLC by email at prospectus-eq_fi@jpmchase.com or postsalemanualrequests @FILTHYLUCRE-271-7403; Truist Securities, Inc toll-free at +1-800-685-4786; or Wells Fargo Securities, LLC toll-free at +1-800-645-3751. An electronic copy of the registration statement and prospectus supplement, together with the base prospectus, is available on the SEC’s website at www.sec.gov.


This news release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.


Cautionary Statement


This news release includes forward-looking statements regarding Humana within the meaning of the Private Securities Litigation Reform Act of 1995. When used in investor presentations, press releases, SEC filings, and in oral statements made by or with the approval of one of Humana’s executive officers, the words or phrases like “expects,” “believes,” “anticipates,” “assumes,” “intends,” “likely will result,” “estimates,” “projects” or variations of such words and similar expressions are intended to identify such forward-looking statements.


These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions, including, among other things, information set forth in the “Risk Factors” section of the company’s SEC filings, a summary of which includes but is not limited to the following:



If Humana does not design and price its products properly and competitively, if the premiums Humana receives are insufficient to cover the cost of healthcare services delivered to its members, if the company is unable to implement clinical initiatives to provide a better healthcare experience for its members, lower costs and appropriately document the risk profile of its members, or if its estimates of benefits expense are inadequate, Humana’s profitability could be materially adversely affected. Humana estimates the costs of its benefit expense payments, and designs and prices its products accordingly, using actuarial methods and assumptions based upon, among other relevant factors, claim payment patterns, medical cost inflation, and historical developments such as claim inventory levels and claim receipt patterns. The company continually reviews estimates of future payments relating to benefit expenses for services incurred in the current and prior periods and makes necessary adjustments to its reserves, including premium deficiency reserves, where appropriate. These estimates involve extensive judgment, and have considerable inherent variability because they are extremely sensitive to changes in claim payment patterns and medical cost trends. Accordingly, Humana’s reserves may be insufficient.



If Humana fails to effectively implement its operational and strategic initiatives, including its Medicare initiatives, which are of particular importance given the concentration of the company’s revenues in these products, state-based contract strategy, the growth of its CenterWell business, and its integrated care delivery model, the company’s business may be materially adversely affected.



The number of Humana’s Medicare Advantage plans rated 4-star or higher significantly declined in 2025. Humana filed a lawsuit seeking to set aside and vacate the 2025 Star Ratings of its Medicare Advantage plans, and on October 14, 2025, the Court issued a decision rejecting Humana’s challenge. Although the company has appealed that decision, there can be no assurances that it will ultimately prevail in the lawsuit. If the company is not successful, the decline in Star Ratings will negatively impact its 2026 quality bonus payments from Centers for Medicare and Medicaid Services (“CMS”) and may also significantly adversely affect the company’s revenues, operating results, and cash flows. In addition, there can be no assurances the company will be successful in maintaining or improving its Star Ratings in future years.



If Humana, or the third-party service providers on which it relies, fails to properly maintain the integrity of its data, to strategically maintain existing or implement new information systems (including systems powered by or incorporating artificial intelligence (AI) or machine learning (ML)), or to protect Humana’s proprietary rights to its systems, or to defend against cyber-security attacks, contain such attacks when they occur, or prevent other privacy or data security incidents that result in security breaches that disrupt the company’s operations or in the unintentional dissemination of sensitive personal information or proprietary or confidential information, the company’s business may be materially adversely affected.



Humana is involved in various legal actions, or disputes that could lead to legal actions (such as, among other things, provider contract disputes and qui tam litigation brought by individuals on behalf of the government), governmental and internal investigations, and routine internal review of business processes any of which, if resolved unfavorably to the company, could result in substantial monetary damages or changes in its business practices. Increased litigation and negative publicity could also increase the company’s cost of doing business.



As a government contractor, Humana is exposed to risks that may materially adversely affect its business or its willingness or ability to participate in government healthcare programs including, among other things, loss of material government contracts; governmental audits and investigations; potential inadequacy of government determined payment rates; potential restrictions on profitability, including by comparison of profitability of the company’s Medicare Advantage business to non-Medicare Advantage business; or other changes in the governmental programs in which Humana participates. Changes to the risk-adjustment model utilized by CMS to adjust premiums paid to Medicare Advantage plans or retrospective recovery by CMS of previously paid premiums as a result of the final rule related to the risk adjustment data validation audit methodology published by CMS on January 30, 2023 (Final RADV Rule), which Humana believes fails to address adequately the statutory requirement of actuarial equivalence and violates the Administrative Procedure Act due to its failure to include a “Fee for Service Adjuster” could have a material adverse effect on the company’s operating results, financial position and cash flows.



Humana’s business activities are subject to substantial government regulation. New laws or regulations, or legislative, judicial, or regulatory changes in existing laws or regulations or their manner of application could increase the company’s cost of doing business and have a material adverse effect on Humana’s results of operations (including restricting revenue, enrollment and premium growth in certain products and market segments, restricting the company’s ability to expand into new markets, increasing the company’s medical and operating costs by, among other things, requiring a minimum benefit ratio on insured products, lowering the company’s Medicare payment rates and increasing the company’s expenses associated with a non-deductible health insurance industry fee and other assessments); the company’s financial position (including the company’s ability to maintain the value of its goodwill); and the company’s cash flows.



Humana’s failure to manage acquisitions, divestitures and other significant transactions successfully may have a material adverse effect on the company’s results of operations, financial position, and cash flows.



If Humana fails to develop and maintain satisfactory relationships with the providers of care to its members, the company’s business may be adversely affected.



Humana faces significant competition in attracting and retaining talented employees. Further, managing succession for, and retention of, key executives is critical to the company’s success, and its failure to do so could adversely affect the company’s businesses, operating results and/or future performance.



Humana’s pharmacy business is highly competitive and subjects it to regulations and supply chain risks in addition to those the company faces with its core health benefits businesses.



Changes in the prescription drug industry pricing benchmarks may adversely affect Humana’s financial performance.



Humana’s ability to obtain funds from certain of its licensed subsidiaries is restricted by state insurance regulations.



Downgrades in Humana’s debt ratings, should they occur, may adversely affect its business, results of operations, and financial condition.



Volatility or disruption in the securities and credit markets may significantly and adversely affect the value of Humana’s investment portfolio and the investment income that Humana derives from this portfolio.



In making forward-looking statements, Humana is not undertaking to address or update them in future filings or communications regarding its business or results. In light of these risks, uncertainties, and assumptions, the forward-looking events discussed herein may or may not occur. There also may be other risks that the company is unable to predict at this time. Any of these risks and uncertainties may cause actual results to differ materially from the results discussed in the forward-looking statements.


Humana advises investors to read the Form 10-K for the year ended December 31, 2025 as filed by the company with the SEC for further discussion both of the risks it faces and its historical performance.


About Humana


Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260305445361/en/
Lisa Stoner

Humana Investor Relations

502-580-2652

e-mail: lstamper@humana.com


Mark Taylor

Humana Corporate Communications

317-753-0345

e-mail: mtaylor108@humana.com


Original: Humana Prices $1.0 Billion Fixed-to-Fixed Rate Junior Subordinated Notes Offering

Humana Introduces New Value-Based Cardiology Care Partnerships for Medicare Advantage MembersMarch 3, 2026 11:45 AM
Business Wire
Humana Inc. (NYSE: HUM), a leading U.S. healthcare company, today announced new partnerships to improve heart health for eligible Medicare Advantage members through value-based care. Building on Humana’s existing cardiac care partnership with CVAUSA’s Novocardia Care Solutions division, new agreements with Karoo Health, US Heart and Vascular and Chamber Cardio further expand the company’s comprehensive cardiac care program.


What This Means for Medicare Advantage Members


Eligible Humana Individual and Group Medicare Advantage members will have access, through their participating cardiologists, to enhanced cardiac care services designed to improve quality of life and reduce hospitalizations. Key features include:



Value-based care teams: Focus on proactive, evidence-based care to help members stay healthier, prevent complications, and reduce unnecessary emergency visits.



24/7 hotline: Round-the-clock access to a coordinated care team and resources make it simpler for members to manage heart conditions.



Remote monitoring tools: Localized teams monitor heart rate, rhythm, blood pressure and other indicators to identify needed adjustments before issues escalate.



Integrated team support: Care management team and participating cardiologists collaborate on personalized care plans, ensuring tests, medication and diet align with members’ needs.



Why It Matters


“Managing a heart condition can feel overwhelming. Our members need integrated, coordinated, evidence-based care that meets them where they are,” said Caraline Coats, Senior Vice President Clinical Strategy at Humana. “As a leader in value-based care, Humana is committed to expanding access to high-quality, whole-person care that supports better health outcomes.”


Value-based care incentivizes holistic, coordinated, effective care to deliver better health outcomes. Humana’s analysis has found that value-based care leads to a higher quality of care and better adherence to evidence-based medicine for cardiac patients.


Where These Services Are Available


Individual and Group Humana Medicare Advantage members now have access to:



CVAUSA's Novocardia Care Solutions services in Florida, Georgia, South Carolina, Illinois, North Carolina and Iowa.



Karoo Health services in Arizona, Illinois, Alabama, Mississippi and Louisiana.



Chamber Cardio services in Maryland, Georgia, South Carolina, North Carolina, Virginia, Washington, DC, and Texas.



US Heart and Vascular services in Alabama, Arizona, Louisiana, Texas and Kansas.



Other providers are available in the Humana network. Provider may also contract with other plan sponsors.


About Humana


Humana (NYSE:HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.


Y0040_ GHHMY4GEN_C

View source version on businesswire.com: https://www.businesswire.com/news/home/20260303129843/en/
Media Contact

Kristen Schabert

Humana Corporate Communications

kschabert@humana.com


Original: Humana Introduces New Value-Based Cardiology Care Partnerships for Medicare Advantage Members

$HUM American Doctor Caleb Masterson reveals that 50% of patients that have been approved for a prior authorization before surgery, then have their coverage denied after the surgery is completed

“Half of all united Surgeries that are prior auth approved get subsequently denied”

Americans health insurance companies are running a racket

He says they make them jump through more pointless hoops just to get the same approval they already had. The are dragging out the process hoping people give up

American Doctor Caleb Masterson reveals that 50% of patients that have been approved for a prior authorization before surgery, then have their coverage denied after the surgery is completed

Humana Board Declares Payment of Quarterly Dividend to StockholdersFebruary 19, 2026 6:30 AM
Business Wire
Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on April 24, 2026 to stockholders of record as of the close of business on March 27, 2026.


About Humana


Humana (NYSE:HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260219028095/en/
Lisa Stoner

Humana Investor Relations

(502) 580-2652

e-mail: lstamper@humana.com


Mark Taylor

Humana Corporate Communications

(317) 753-0345

e-mail: Mtaylor108@humana.com


Original: Humana Board Declares Payment of Quarterly Dividend to Stockholders

Humana Invests $1.7 Million to Drive Better Health Outcomes Across IllinoisFebruary 18, 2026 8:45 AM
Business Wire
Grants will support key state priorities crucial to improving population health


Leading health and wellbeing company Humana Inc. (NYSE: HUM) has committed more than $1.7 million in strategic investments to support housing stability and workforce development, reduce disparities, and expand access to maternal and behavioral healthcare services across Illinois. In partnering with leading community organizations who have a keen understanding of their neighbors’ needs, Humana is further addressing its commitment to address health-related social needs and advance priorities outlined by the Illinois Department of Healthcare and Family Services (HFS).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260218298352/en/Humana is investing in community programs to help address health-related social needs in Illinois.
“Our goal is to ensure that every Illinoisan has the resources they need to achieve their best health, and we can’t do that alone,” said Samantha Olds Frey, President, Humana – Illinois. “Success requires collaboration, and we are grateful to work together with HFS and our non-profit partners to build healthy communities across the state.”


This investment builds on previous grants aimed at addressing urgent needs such as food and housing instability, bringing Humana’s total commitment to more than $3 million. 2026 grant recipients include:



Brightpoint: Schubert Family Wellness Center + Behavioral Health & Wellness Consultant: Located at Schubert Elementary in Chicago’s Belmont Cragin neighborhood, The Family Wellness Center embeds a school-based hub for behavioral health, family supports, and wraparound care, and other prevention-based services, meeting children and families where they are.



Illinois Public Health Association: Supporting the Forward 4 Families Hub, which will build a statewide Community Health Worker (CHW) infrastructure focused on maternal and child health, embedding CHWs in high-disparity counties to navigate prenatal care, postpartum coverage, and social needs.



Illinois Rural Health Association: Addresses the shortage of dentists in rural Illinois by funding five dental scholarships at Southern Illinois University. Scholarships are awarded to students who plan to practice in a rural, medically underserved area.



Southern Illinois University School of Medicine Behavioral Health Workforce Center: Grows licensed behavioral health workforce pipelines across central and southern Illinois and delivers Extension for Community Healthcare Outcomes (ECHO) collaboratives that extend specialist support into rural communities.



National Alliance on Mental Illness (NAMI) Illinois: Expands behavioral health awareness, peer support, and school-based education statewide. NAMI’s youth programs are embedded in schools and communities and align with Illinois’ behavioral health priorities, offering reach across both rural and urban geographies.



SIHF Healthcare: Leads Community Health Worker-driven chronic disease management in Metro East, aligning with Health Transformation Collaboratives



Humana’s latest investments further reflect the company’s expertise in delivering integrated healthcare to populations with complex health-related social needs, including food insecurity. In alignment with its Fully Integrated Dual Eligible Special Needs Plan in Illinois, Humana has provided grants to numerous organizations including Feeding Illinois and the Northern Illinois Food Bank.


About Humana


Humana (NYSE:HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260218298352/en/
Angie Weiss

Humana Corporate Communications

aweiss3@humana.com


Original: Humana Invests $1.7 Million to Drive Better Health Outcomes Across Illinois

CenterWell Completes Acquisition of MaxHealth From Arsenal Capital PartnersFebruary 13, 2026 4:15 PM
Business Wire

MaxHealth is a Florida-based primary care organization with a network of 82 owned and affiliated clinics, providing care to more than 80,000 patients in value-based care programs.



CenterWell Senior Primary Care is the nation’s largest senior-focused, value-based primary care provider.



The acquisition will expand the reach of CenterWell Senior Primary Care to new key markets and allow it to serve more patients with CenterWell’s unique approach to personalized and integrated care.



CenterWell, the healthcare services division of Humana Inc., today announced the successful completion of its acquisition of MaxHealth from Arsenal Capital Partners (“Arsenal”), a private equity investment firm that specializes in building market-leading industrial growth and healthcare companies, and MaxHealth’s founder-shareholders. MaxHealth currently maintains a network of 54 owned primary care clinics, 4 owned specialty/ancillary clinics and 24 downstream affiliate clinics throughout West and South Florida that together provide high-quality, integrated care to more than 120,000 patients, including more than 80,000 patients in value-based care programs.


MaxHealth will now be affiliated with and owned by CenterWell Senior Primary Care, the nation’s largest senior-focused, value-based primary care provider. The acquisition will expand the reach of CenterWell Senior Primary Care to new key markets and allow it to serve more patients with CenterWell’s unique approach to personalized and integrated care. Financial terms of the transaction were not disclosed.


“We are pleased to complete the acquisition of MaxHealth and are excited to welcome their dedicated team of clinicians and staff to CenterWell Senior Primary Care,” said Sanjay Shetty, M.D., President of CenterWell. “MaxHealth is a patient-centered, results-driven organization that simplifies the healthcare experience and empowers patients to live their best lives – values that align closely with everything we do at CenterWell. Together, we will make an even bigger difference for those we serve.”


“MaxHealth was built through the collective efforts of physician-founded organizations and a remarkable team committed to reshaping healthcare delivery in Florida,” said Kimberly Ficocelli, Co-Founder of MaxHealth. “From the very beginning, we set out to build a platform grounded in strong provider alignment, patient-first care, and a disciplined approach to growth. Arsenal understood that vision, and our partnership helped turn it into a scaled, durable organization. I am incredibly proud of what this team has built and excited for the impact MaxHealth will continue to have for patients and communities across the state under the stewardship of CenterWell.”


“This milestone reflects the extraordinary work of the founders who built MaxHealth, the physicians who deliver exceptional care every day, and the teammates across our organization who bring our mission to life,” said Michelle Leslie, Chief Executive Officer of MaxHealth. “We are deeply grateful to Arsenal Capital Partners for its partnership and support during a period of meaningful growth. As we join CenterWell, we are excited to build on this strong foundation and further expand access to high-quality, patient-centered care for the communities we serve.”


“We are proud of the founders and the MaxHealth team in how they have set the standard for delivering high-quality care for patients across Florida,” said Martin Coulter, Chairman of MaxHealth and an Operating Partner of Arsenal. “As part of the CenterWell organization, MaxHealth is positioned for continued growth and scaling of its platform. We are delighted to have supported the company and its management team through this chapter and are grateful to the Humana and CenterWell leadership teams for their collaboration and partnership as MaxHealth begins the next leg of its journey."


Guggenheim Securities, LLC served as the lead financial advisor to MaxHealth, and Morgan Stanley also acted as financial advisor to the company. Sidley Austin LLP served as legal counsel to MaxHealth. For Humana and CenterWell, J.P. Morgan Securities LLC served as financial advisor and Latham & Watkins LLP served as legal counsel.


About CenterWell


CenterWell is a leading healthcare services business focused on creating integrated and differentiated experiences that put our patients at the center of everything we do. The result is high-quality healthcare that is accessible, comprehensive and, most of all, personalized. As the largest provider of senior-focused primary care, a leading provider of home healthcare and a leading integrated home delivery, specialty, hospice and retail pharmacy, CenterWell is focused on whole health and addressing the physical, emotional and social wellness of our patients. CenterWell is part of Humana Inc. (NYSE: HUM). Learn more about what we offer at CenterWell.com.


About MaxHealth


MaxHealth is dedicated to simplifying healthcare and ensuring healthier futures. Founded in 2015, MaxHealth is a leading primary care platform focused on providing high-quality, integrated care to adults and senior patients throughout Florida. Its patients are supported by a 530-member team that includes 100+ primary care providers and 30+ specialists across 58 owned clinics and 24 affiliated clinics.


MaxHealth was founded by three provider organizations: (1) Best Value Healthcare founded by Dr. Rajankumar Naik, Kimberly Ficocelli and Dillon Moore; (2) MAXhealth founded by Tom Blankenship, Neil Bedi and Inita Bedi; and (3) Primary Care Associates founded by Dr. Paul Pulcini and Gladymar Vrkic. These three organizations came together along with an additional 13 independent providers under the common ownership of Arsenal Capital Partners.


About Arsenal Capital Partners


Arsenal Capital Partners (“Arsenal”) is a private equity investment firm that specializes in building market-leading industrial growth and healthcare companies. Since its inception in 2000, Arsenal has raised institutional equity investment funds totaling over $10 billion, completed more than 300 platform and add-on acquisitions and achieved more than 35 realizations. Driven by our commitment to unlock potential in people, businesses, and technologies, the firm partners with management teams to build strategically important companies with leading market positions, high growth and high value-add. For more information, visit www.arsenalcapital.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260213106397/en/
Investors - Humana: Lisa Stoner - lstamper@humana.com

Media - CenterWell: Mark Taylor - MTaylor108@humana.com

Media - Arsenal Capital Partners: Ellen Pavlovsky - epavlovsky@arsenalcapital.com


Original: CenterWell Completes Acquisition of MaxHealth From Arsenal Capital Partners

CenterWell Completes Acquisition of MaxHealth from Arsenal Capital PartnersFebruary 13, 2026 4:15 PM
PR Newswire (US)

MaxHealth is a Florida-based primary care organization with a network of 82 owned and affiliated clinics, providing care to more than 80,000 patients in value-based care programs.CenterWell Senior Primary Care is the nation's largest senior-focused, value-based primary care provider.The acquisition will expand the reach of CenterWell Senior Primary Care to new key markets and allow it to serve more patients with CenterWell's unique approach to personalized and integrated care.LOUISVILLE, Ky. and TAMPA, Fla. and NEW YORK, Feb. 13, 2026 /PRNewswire/ -- CenterWell, the healthcare services division of Humana Inc., today announced the successful completion of its acquisition of MaxHealth from Arsenal Capital Partners ("Arsenal"), a private equity investment firm that specializes in building market-leading industrial growth and healthcare companies, and MaxHealth's founder-shareholders. MaxHealth currently maintains a network of 54 owned primary care clinics, 4 owned specialty/ancillary clinics and 24 downstream affiliate clinics throughout West and South Florida that together provide high-quality, integrated care to more than 120,000 patients, including more than 80,000 patients in value-based care programs.







MaxHealth will now be affiliated with and owned by CenterWell Senior Primary Care, the nation's largest senior-focused, value-based primary care provider. The acquisition will expand the reach of CenterWell Senior Primary Care to new key markets and allow it to serve more patients with CenterWell's unique approach to personalized and integrated care. Financial terms of the transaction were not disclosed."We are pleased to complete the acquisition of MaxHealth and are excited to welcome their dedicated team of clinicians and staff to CenterWell Senior Primary Care," said Sanjay Shetty, M.D., President of CenterWell. "MaxHealth is a patient-centered, results-driven organization that simplifies the healthcare experience and empowers patients to live their best lives – values that align closely with everything we do at CenterWell. Together, we will make an even bigger difference for those we serve.""MaxHealth was built through the collective efforts of physician-founded organizations and a remarkable team committed to reshaping healthcare delivery in Florida," said Kimberly Ficocelli, Co-Founder of MaxHealth. "From the very beginning, we set out to build a platform grounded in strong provider alignment, patient-first care, and a disciplined approach to growth. Arsenal understood that vision, and our partnership helped turn it into a scaled, durable organization. I am incredibly proud of what this team has built and excited for the impact MaxHealth will continue to have for patients and communities across the state under the stewardship of CenterWell.""This milestone reflects the extraordinary work of the founders who built MaxHealth, the physicians who deliver exceptional care every day, and the teammates across our organization who bring our mission to life," said Michelle Leslie, Chief Executive Officer of MaxHealth. "We are deeply grateful to Arsenal Capital Partners for its partnership and support during a period of meaningful growth. As we join CenterWell, we are excited to build on this strong foundation and further expand access to high-quality, patient-centered care for the communities we serve.""We are proud of the founders and the MaxHealth team in how they have set the standard for delivering high-quality care for patients across Florida," said Martin Coulter, Chairman of MaxHealth and an Operating Partner of Arsenal. "As part of the CenterWell organization, MaxHealth is positioned for continued growth and scaling of its platform. We are delighted to have supported the company and its management team through this chapter and are grateful to the Humana and CenterWell leadership teams for their collaboration and partnership as MaxHealth begins the next leg of its journey." Guggenheim Securities, LLC served as the lead financial advisor to MaxHealth, and Morgan Stanley also acted as financial advisor to the company. Sidley Austin LLP served as legal counsel to MaxHealth. For Humana and CenterWell, J.P. Morgan Securities LLC served as financial advisor and Latham & Watkins LLP served as legal counsel.About Arsenal Capital Partners
Arsenal Capital Partners ("Arsenal") is a private equity investment firm that specializes in building market-leading industrial growth and healthcare companies. Since its inception in 2000, Arsenal has raised institutional equity investment funds totaling over $10 billion, completed more than 300 platform and add-on acquisitions and achieved more than 35 realizations. Driven by our commitment to unlock potential in people, businesses and technologies, the firm partners with management teams to build strategically important companies with leading market positions, high growth and high value-add. For more information, visit www.arsenalcapital.com.About CenterWell 
CenterWell is a leading healthcare services business focused on creating integrated and differentiated experiences that put our patients at the center of everything we do. The result is high-quality healthcare that is accessible, comprehensive and, most of all, personalized. As the largest provider of senior-focused primary care, a leading provider of home healthcare and a leading integrated home delivery, specialty, hospice and retail pharmacy, CenterWell is focused on whole health and addressing the physical, emotional and social wellness of our patients. CenterWell is part of Humana Inc. (NYSE: HUM). Learn more about what we offer at CenterWell.com.About MaxHealth
MaxHealth is dedicated to simplifying healthcare and ensuring healthier futures. Founded in 2015, MaxHealth is a leading primary care platform focused on providing high-quality, integrated care to adults and senior patients throughout Florida. Its patients are supported by a 530-member team that includes 100+ primary care providers and 30+ specialists across 58 owned clinics and 24 affiliated clinics.MaxHealth was founded by three provider organizations: (1) Best Value Healthcare founded by Dr. Rajankumar Naik, Kimberly Ficocelli and Dillon Moore; (2) MAXhealth founded by Tom Blankenship, Neil Bedi and Inita Bedi; and (3) Primary Care Associates founded by Dr. Paul Pulcini and Gladymar Vrkic. These three organizations came together along with an additional 13 independent providers under the common ownership of Arsenal Capital Partners.FOR MORE INFORMATION CONTACT:Investors - Humana:                          Lisa Stoner - lstamper@humana.com
Media - CenterWell:                           Mark Taylor - MTaylor108@humana.com
Media - Arsenal Capital Partners:    Ellen Pavlovsky - epavlovsky@arsenalcapital.com



View original content to download multimedia:https://www.prnewswire.com/news-releases/centerwell-completes-acquisition-of-maxhealth-from-arsenal-capital-partners-302688056.htmlSOURCE Arsenal Capital Partners

Original: CenterWell Completes Acquisition of MaxHealth from Arsenal Capital Partners

Humana stock slides on weaker-than-expected 2026 outlookFebruary 11, 2026 6:48 AM
IH Market News
Shares of Humana Inc. (NYSE:HUM) dropped 5.1% in premarket trading after the health insurer issued 2026 earnings guidance that came in well below Wall Street forecasts, overshadowing stronger-than-anticipated fourth-quarter results.For the fourth quarter of 2025, the Medicare Advantage provider reported an adjusted net loss of $3.96 per share, slightly narrower than analysts’ expectations of a $4.00 per share loss. Revenue totaled $32.52 billion, surpassing the consensus estimate of $32.04 billion.Investor reaction centered on the company’s 2026 adjusted earnings projection of “at least $9.00” per share, significantly under the $12.00 analysts had been expecting. Management said the anticipated year-over-year decline reflects a “Star Ratings headwind for Bonus Year 2026, net of mitigation.”For full-year 2025, Humana posted adjusted earnings of $17.14 per share, up from $16.21 in 2024. Within its Insurance segment, the company recorded a GAAP benefit ratio of 90.4% for the year, slightly better than prior guidance of “the top end of the range of 90.1% to 90.5%.”“We were pleased with our solid financial performance and operational progress in 2025,” said Humana President and CEO Jim Rechtin. “We continue to feel good about our consumer-focused strategy and our individual Medicare Advantage membership growth in 2026, which will allow us to build for the future with even better outcomes and experiences.”Despite the softer earnings outlook, Humana expects individual Medicare Advantage membership to expand by roughly 25% in 2026, driven by new enrollments and improved retention rates. The company also pointed to ongoing momentum in its CenterWell healthcare services platform, which saw a 25% rise in Senior Primary Care patients during 2025.Humana stock price

Original: Humana stock slides on weaker-than-expected 2026 outlook

Humana Named KCTCS Education First Employer, Announces Humana Scholars Program for Nursing StudentsFebruary 5, 2026 10:00 AM
Business Wire
Humana is investing in a new program with Jefferson Community and Technical College to strengthen and support Kentucky’s nursing workforce.


In announcing the launch of the Humana Scholars program, Humana joins the Kentucky Community and Technical College System (KCTCS) network of Education First Employers, partnering with the system’s Louisville campus, Jefferson.


Humana is investing a total of $125,000 in the Humana Scholars program, which includes two components – a Scholarship Fund and a Student Support Fund – to help train and support a pipeline of skilled nurses. The program will offer both scholarships and help reduce barriers, like food insecurity or lack of transportation, for first-year nursing students at Jefferson interested in a home health nursing career. Eight students will be selected initially.


“The Humana Scholars program supports education in the communities that we serve. It also addresses a critical workforce shortage in home health nursing,” said Jim Rechtin, CEO of Humana. Rechtin said the company is committed to expanding exposure to home health as a career path, as well as reducing financial and other barriers for nurses considering this option. “That’s what we want to do – invest in our local communities while building a pipeline of skilled, compassionate nurses. No better place to start than here at home in Kentucky.”


While the Humana Scholars program is initially offered at Jefferson, it is designed as a core component of Humana’s broader Education First Employer partnership with KCTCS. Other colleges in the system may be added to the Humana Scholars program later. Jefferson was selected as the initial site based on its scale, program mix, and proximity to Humana’s workforce in Louisville.


Home health is one of the fastest-growing areas of healthcare, driven by an aging population, advances in technology that allow more complex care to be delivered in the home, and patient preference to receive care in the most comfortable and cost-effective setting. Home health nurses play a critical role in helping patients recover from illness, manage chronic conditions, avoid unnecessary hospitalizations, and maintain independence.


CenterWell Home Health, part of Humana’s health care services division, is one of America’s leading providers of home health care, providing home-centered health care in 37 states. Including CenterWell as well as other lines of business, Humana employs more than 10,000 nurses.


The Humana Scholars partnership with Jefferson is the third initiative in the past year in which Humana has partnered with other organizations to support the nursing workforce. The other initiatives were:



In December, Humana announced a partnership with the national Nurses on Boards Coalition (NOBC) to provide mentors for nursing students. Humana is providing a gift of $110,000 for first-year funding to support the NOBC’s Mentoring for Success program, which will match 50 nursing students with 50 mentors who work as nurses for Humana.



Last February, Humana contributed $75,000 in a partnership with Eastern Kentucky University and Kentucky state government to support a home health simulation center on campus and to equip faculty with resources to help students who may be struggling with social needs.



The partnership with Jefferson continues to advance Humana’s twin goals of education and personalized support for emerging nurses. “We were committed early on to a traditional scholarship as well as a support fund,” said Kathy Driscoll, MSN, RN, NEA-BC, CCM, chief nursing officer for Humana.


“What we have found, is that academic scholarships alone are not enough to support our future nurses through their nursing journey. Many good candidates have additional needs that might otherwise hinder that journey, such as childcare and transportation issues. It’s important that we help minimize those issues so students can keep their focus on their education and continue to succeed upon graduation.”


Dr. Ryan Quarles, president of KCTCS, said the partnership with Humana is an important collaboration between education and business in Kentucky.


“Humana’s commitment to investing in its people makes them an outstanding addition to KCTCS’s Education First Employers program,” Dr. Quarles said. “We are excited to partner with one of Kentucky’s largest employers to prioritize education and workforce training for Kentuckians. This partnership reflects our shared priority for accessible education and continuous learning that help strengthen individuals and communities. The Education First Employers program helps employees advance their skills, achieve educational goals, and build long-term economic stability.”


KCTCS launched the Education First Employer initiative in 2023 in partnership with Gov. Andy Beshear, TEAM Kentucky, and Family Scholar House. Companies that qualify to participate in the program share similar values and have shown a commitment to go above and beyond to support employees through education and training.


The program recognizes organizations in key sectors that are dedicated to promoting accessible education and investing in their workforce. The designation helps companies attract and retain quality, engaged employees, which enhances the skillset of Kentucky’s workforce. Participants are supported as both students and employees, allowing more Kentuckians to achieve educational attainment and economic stability.


About Humana


Humana Inc. (NYSE:HUM) is a leading U.S. healthcare company. Through our Humana insurance services, and our CenterWell health care services, we strive to make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.


About Jefferson and the Kentucky Community and Technical College System


Jefferson Community and Technical College (Jefferson) is the largest of the 16 colleges forming the Kentucky Community and Technical College System (KCTCS). Jefferson prepares students for transfer into baccalaureate programs and for high-wage, high-demand careers. KCTCS is the commonwealth’s largest postsecondary institution with 16 colleges and more than 70 campuses. KCTCS is also Kentucky’s largest provider of workforce training and online classes. Through partnerships with business and industry, we align our programs to meet the needs of local employers. Our colleges are united in their commitment to making life better for our students, communities and the citizens of Kentucky.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260205896063/en/
Cary Willis

Humana Corporate Communications

502-889-6973

cwillis21@humana.com


Nikolette Rost

Jefferson Director of Public Relations

812-989-0920

nikolette.langdon@kctcs.edu


Original: Humana Named KCTCS Education First Employer, Announces Humana Scholars Program for Nursing Students

Humana Report Finds Value-Based Care Improves Outcomes for Medicare Advantage MembersFebruary 4, 2026 8:45 AM
Business Wire

Medicare Advantage members in value-based care arrangements had 24.3% fewer inpatient hospital admissions than those in Original Medicare in 2024.




Humana Medicare Advantage members receiving value-based care had 13.4% fewer emergency department visits and 7.6% fewer hospital admissions than members in non-value-based care arrangements.




Medicare Advantage members receiving value-based care reported higher satisfaction with their care, including a 13-point higher Net Promoter Score than those using fee-for-service.



Humana Inc. (NYSE: HUM), a health and well-being company focused on helping people live their healthiest lives, today released its latest Value-Based Care By the Numbers Report. The findings show that value-based care helps Medicare Advantage patients receive more personalized, preventive care while improving their overall health experience.


The report draws on Humana’s leadership in value-based care and 2024 data showing that Medicare Advantage members receiving care under value-based arrangements experience fewer unnecessary emergency department visits, fewer hospitalizations, higher satisfaction, and more preventive care. These results demonstrate that value-based care is not only a better way to deliver better health outcomes — it’s a smarter model to create a sustainable healthcare system.


Why Value-Based Care Matters


“Value-based care means seeing the whole patient — not just the chart. It’s the reason I chose medicine in the first place. Every path in value-based care leads to one goal: helping people achieve their best health,” said Alex Ding, M.D., Deputy Chief Medical Officer at Humana. “It’s about proactively delivering the right care, understanding individual needs, and making sure every patient feels seen and supported.”


The report also highlights benefits for clinicians, including more time with patients and improved primary care practice sustainability – contributing to lower rates of clinician burnout and improved care delivery.


Value-based care enables a team of clinicians to holistically, proactively care for a patient’s care needs. In contrast, the fee-for-service model puts clinicians in a reactive stance with no incentives to deliver preventive care or to reduce costly, low-value care. Value-based care shifts the priority from patient volume to patient health outcomes.


Humana’s newest Value-Based Care By the Numbers Report reaffirms over a decade of evidence that value-based care models deliver a better healthcare system for patients and clinicians.


Impact on Patients: Less Time Spent in the Hospital


According to Humana’s 2024 analysis, Medicare Advantage members receiving care from value-based clinicians spent less time in the hospital and were less likely to rely on emergency care compared with patients in non-value-based arrangements.



24.3% fewer inpatient admissions for value-based care patients with Medicare Advantage plans versus those enrolled in Original Medicare in 2024



13.4% fewer emergency department visits and 7.6% fewer admissions for Humana Medicare Advantage members treated by value-based clinicians than those not in a value-based arrangement



Improved Management of Chronic Conditions


The report also highlights stronger chronic disease management for Medicare Advantage members in value-based care arrangements, particularly among older adults managing multiple conditions.



More eye exam screenings and kidney health evaluations for members who have diabetes



Higher use of statin therapy for members with cardiovascular disease



Higher medication adherence rates for hypertension and diabetes medication



More Preventive Care


Preventive care remains a cornerstone of value-based care. Humana’s analysis of its Medicare Advantage, value-based care members found higher rates of:



breast cancer screening



colorectal cancer screening



osteoporosis management



Higher Patient Satisfaction


In addition to clinical improvements, patients reported:



Higher patient satisfaction of their health plan, health care, care coordination, customer service, and more for Humana Medicare Advantage members receiving value-based care per Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey data



13 points higher Net Promoter Score for Medicare Advantage members receiving value-based care than those with fee-for-service providers



Helping Older Adults Thrive with Personalized Primary Care


For older adults managing multiple chronic conditions, value-based care offers a more coordinated and proactive approach than traditional fee-for-service models. According to the CenterWell Aging Well in America survey, conducted with Morning Consult, older adults identified their primary care provider as the most important factor, other than themselves, in their ability to age well.


Research published in NEJM Catalyst by Humana Healthcare Research found that patients receiving care from senior-focused primary care providers experienced:



20% more primary care visits per year



6% more regularly scheduled visits



Higher continuity of care (75% of senior-focused primary care patients vs. 55% of FFS patients)



Expanding Value-Based Care Across the System


Beyond primary care models, Humana’s report also identifies opportunities to extend value-based care into specialty care. For example, Medicare Advantage patients diagnosed with heart failure experience a higher quality of care and better evidence-based medication prescription adherence under value-based care arrangements.


“Value-based care is no longer an aspiration – it's a necessity,” said George Renaudin, Humana’s Insurance President. “Insurers, providers and clinicians must work together to accelerate adoption. All efforts should center on helping patients live healthier for longer while enabling a healthcare system that is more sustainable.”


To support this transition, Humana is investing in technology and data-sharing capabilities that enable providers to deliver more coordinated care. In October, Humana and Providence announced a new data exchange initiative using national interoperability standards to streamline secure data sharing. This collaboration supports upcoming regulations from the Centers for Medicare & Medicaid Services (CMS) and aims to reduce administrative burden and improve care coordination for Medicare Advantage members.


Read Humana’s Value-Based Care By the Numbers Report in full here.


About Humana


Humana Inc. (NYSE: HUM) is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we strive to make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260204149294/en/
Media Contact

Kristen Schabert

Humana Corporate Communications

kschabert@humana.com


Original: Humana Report Finds Value-Based Care Improves Outcomes for Medicare Advantage Members

Zynex Announces New In-Network Provider Status with HumanaFebruary 4, 2026 8:39 AM
PR Newswire (US)

ENGLEWOOD, Colo., Feb. 4, 2026 /PRNewswire/ -- Zynex, Inc. (ZYXIQ), an innovative medical device company specializing in non-invasive medical devices for pain management, announced it has for the first time entered into a provider agreement with Humana Inc. (NYSE: HUM), effective February 1, 2026."Our non-invasive medical technology improves quality of life for patients with debilitating pain and is a safe and effective alternative for pain management," said Kurt Hudson, Executive Vice President of Marketing. "We are pleased to offer our advanced electrotherapy products, including our NexWave™ device, to in-network Humana members."Consistently ranked as one of the largest health insurance companies in the United States, and the second-largest provider of Medicare Advantage plans, Humana continues to be a leader among insurers, serving nearly 20 million people across all fifty states. Humana offers products and services through traditional and consumer choice health plans to employer groups, government-sponsored plans, and individuals, as well as primary and workplace care through its medical centers and worksite medical facilities."Partnering with a health insurance leader like Humana will expand patient access," added Steven Dyson, Chief Executive Officer. "We thank Humana for trusting our team to serve their members under this agreement and demonstrate how Zynex can provide the highest technology and service standards in the electrotherapy industry with transparency, integrity, and compliance."Zynex is now participating in health benefits plans offered or administered by Humana, including Medicare-PPO Plans, POS Plans, Network PFFS Plans, and HMO Plans, as well as Kentucky Medicaid HMO, Illinois Medicaid Plans and Integrated DSNP Plans, Indiana PathWays for Aging, Ohio Medicaid Plans, Oklahoma Medicaid, South Carolina Medicaid Plans, Virginia Medicaid Plans, and Michigan Medicaid Plans.Terms of the agreement were not disclosed.About Zynex, Inc.
Zynex, founded in 1996, is a pain management device manufacturer and distributor. For additional information, visit: www.zynex.com.Investor Relations Contact:
Vikram Bajaj, CFO 
E-mail: ir@zynex.comMedia Contact:
Britt Logan DiGiulio
E-mail: media@zynex.com



View original content:https://www.prnewswire.com/news-releases/zynex-announces-new-in-network-provider-status-with-humana-302679009.htmlSOURCE Zynex, Inc.

Original: Zynex Announces New In-Network Provider Status with Humana

Humana Redefines the Member Experience with Agent Assist Built with Google CloudFebruary 3, 2026 11:34 AM
PR Newswire (US)

Humana introduces Agent Assist to help member advocates deliver faster, more personalized support, enabled by an expanded partnership with Google CloudLOUISVILLE, Ky. and SUNNYVALE, Calif., Feb. 3, 2026 /PRNewswire/ -- Humana Inc. (NYSE: HUM), a leading U.S. health and well-being company, today announced the launch of Agent Assist, a new solution built with Google Cloud's AI to support Humana's member advocates to deliver more personalized, accurate, and timely answers to member health benefit questions. The initiative marks another step in Humana's broader digital transformation journey, which focuses on improving member experiences through the responsible, transparent and human-centered use of artificial intelligence.







Humana is launching Agent Assist, built with Google Cloud's AI for more personalized and timely answers to questions.With more than 20,000 member advocates handling up to 80 million calls annually, Humana is using Agent Assist to help advocates focus fully on members' needs. Agent Assist summarizes call conversations in real time, anticipates member needs, and quickly surfaces relevant information. This allows advocates to remain fully engaged with members, while technology operates in the background to enhance service quality, accuracy, and consistency.Agent Assist also provides member advocates with proactive guidance, compliance support, and automated call summaries. Together, these capabilities help reduce manual workload, strengthen training, improve consistency across interactions, and ensure advocates can prioritize member needs effectively. Additionally, Agent Assist supports Humana's long-standing Responsible AI commitment and operating principles by incorporating Google Cloud's enterprise-grade capabilities for data privacy, security, and transparency.Built on Humana's agentic AI platform, Agent Assist uses Google Cloud's Vertex AI, Gemini, and Gemini Enterprise for Customer Experience (CX) to help member advocates navigate benefit details or answer eligibility questions, all while preserving a "human in the loop" throughout every interaction. This ensures that advocates remain accountable for member engagement and decision-making, while AI supports their ability to deliver reliable, responsive, and more personalized support. Agent Assist reinforces Humana's commitment to combining technological innovation with human empathy in every member interaction"We are always looking for new ways to enhance the member experience by making those interactions more personalized, accurate, and faster," said Japan Mehta, chief information officer, Humana. "Agent Assist puts responsible innovation directly into the hands of our advocates, helping them to focus on what matters most – helping our members."Agent Assist integrates seamlessly into existing call center systems and is continuously reviewed and monitored to ensure ongoing compliance and performance."Our collaboration with Humana is a blueprint for the future of healthcare—where technology doesn't replace the human element, but radically enhances it," said Chris Sakalosky, vice president, Strategic Industries, Google Cloud. "By integrating Gemini Enterprise for CX, we're giving Humana's advocates an agent that handles the complexity of benefits in the background, so they can focus on the empathy and care that members deserve. This isn't just about efficiency; it's about redefining the standard for member support."Humana member advocates began using Agent Assist in October 2025, with full rollout planned for Humana member service centers in 2026. The expanded collaboration between Humana and Google Cloud has a central goal of redefining how technology can strengthen human connection in healthcare–making every interaction smarter, simpler, and more personal.About Humana
Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.About Google Cloud
Google Cloud is the new way to the cloud, providing AI, infrastructure, developer, data, security, and collaboration tools built for today and tomorrow. Google Cloud offers a powerful, fully integrated, and optimized AI stack with its own planet-scale infrastructure, custom-built chips, generative AI models and development platform, as well as AI-powered applications, to help organizations transform. Customers in more than 200 countries and territories turn to Google Cloud as their trusted technology partner. 



View original content to download multimedia:https://www.prnewswire.com/news-releases/humana-redefines-the-member-experience-with-agent-assist-built-with-google-cloud-302677922.htmlSOURCE Google Cloud

Original: Humana Redefines the Member Experience with Agent Assist Built with Google Cloud

Fed Call and Earnings Wave Take Center Stage as Markets Brace for Volatility: Dow Jones, S&P, Nasdaq, Wall Street FuturesJanuary 28, 2026 10:28 AM
IH Market News
U.S. equity futures were mostly higher early Wednesday as investors positioned cautiously ahead of a packed session featuring a key Federal Reserve policy decision and a heavy slate of corporate earnings. The Fed is widely expected to keep interest rates unchanged, while several mega-cap technology groups are set to report results after U.S. markets close. Elsewhere, gold climbed to yet another all-time high, and reports said China has approved purchases of Nvidia’s H200 artificial intelligence chips for the first time.



S&P 500 and Nasdaq futures advance



Futures tied to major U.S. indices were trading modestly in positive territory, reflecting guarded optimism ahead of the day’s events.By 02:49 ET, Dow futures were up 37 points, or 0.1%, S&P 500 futures had gained 28 points, or 0.4%, and Nasdaq 100 futures were higher by 249 points, or 1.0%.Wall Street closed mixed on Tuesday as investors digested a wave of quarterly earnings. Sentiment was dented by a sharp drop in UnitedHealth (NYSE:UNH), after the healthcare group warned that 2026 revenue would be lower following a federal proposal for a smaller-than-expected increase in Medicare Advantage premiums. The move weighed on the broader health insurance space, with CVS Health (NYSE:CVS) and Humana (NYSE:HUM) both suffering double-digit losses.By the close, the Dow Jones Industrial Average had fallen 0.8%. However, relative strength in technology and automotive stocks helped support the broader S&P 500 and the Nasdaq Composite.Beyond earnings, investors were also monitoring the risk of a partial U.S. government shutdown amid political backlash over fatal shootings involving immigration enforcement agents in Minneapolis, alongside renewed tariff threats from President Donald Trump.Adding to the cautious tone, U.S. consumer confidence sank in January to its lowest level in 12 years, according to data from the Conference Board, highlighting growing unease among households despite an economy that remains resilient but constrained by high inflation and soft hiring.



Fed decision in focus



Against this backdrop, policymakers at the Federal Reserve are expected to leave interest rates unchanged at the conclusion of their meeting later today.Last year, the central bank delivered a series of rate cuts to support a cooling labour market, bringing borrowing costs into a range of 3.5% to 3.75%. Since then, relatively low layoffs and inflation still well above the Fed’s 2% target have reduced the urgency for further easing.As a result, attention is likely to turn to Chair Jerome Powell’s guidance on the future path of rates, particularly after the Fed’s December meeting revealed deep divisions among officials over how policy should evolve. Markets currently do not expect the next rate cut until June.Investors are also closely watching developments around the leadership of the Fed. Powell, whose term as chair ends in May, is facing a criminal investigation launched earlier this month by the Trump administration. Powell has denied any wrongdoing and described the probe as a politically motivated attempt to undermine the Fed’s independence. Trump has repeatedly criticised Powell for not cutting rates more aggressively, arguing that faster easing would help stimulate growth.Although Powell has received support from members of Trump’s Republican Party, it remains unclear whether he will remain on the Fed’s rate-setting board after his term ends. Trump has reportedly been speaking with potential successors, with prediction markets currently viewing BlackRock executive Rick Rieder as the leading candidate.



Earnings deluge



Earnings season remains a dominant theme, with investors facing a flood of results, particularly from large technology companies.After the U.S. market closes, attention will turn to reports from Meta Platforms (NASDAQ:META), Microsoft (NASDAQ:MSFT) and Tesla (NASDAQ:TSLA). These updates are expected to offer fresh insight into the sustainability of the artificial intelligence boom, which has become a major driver of equity markets and, potentially, broader economic growth.Big technology groups have been investing heavily in AI infrastructure, fuelling strong demand for advanced semiconductors and data centres. Reinforcing expectations that this trend could extend into 2026, Europe’s largest listed company, ASML (NASDAQ:ASML), reported stronger-than-expected fourth-quarter bookings and said orders continue to increase.Earlier in the day, investors will also parse earnings from AT&T (NYSE:T), Starbucks (NASDAQ:SBUX) and energy equipment maker GE Vernova (NYSE:GEV).



Gold sets another record



Gold prices surged to a new record above $5,200 an ounce on Wednesday, supported by strong demand for safe-haven assets and continued weakness in the U.S. dollar.Other precious metals remained elevated, with silver and platinum trading close to recent highs. The cautious mood ahead of the Fed decision has underpinned demand for havens.Gold has risen around 20% so far in 2026, building on last year’s strong gains. Heightened geopolitical tensions — including developments in Venezuela and a dispute involving Greenland — alongside uncertainty over U.S. policy have been key drivers of the rally.A weaker dollar has further boosted metals prices. The greenback slid to a near four-year low this week after Trump signalled on Tuesday that he was unconcerned by the currency’s decline, prompting additional selling.



China clears purchases of Nvidia’s H200 chips – reports



China has approved the purchase of an initial batch of Nvidia’s (NASDAQ:NVDA) H200 artificial intelligence chips, according to media reports.Authorities have reportedly authorised major domestic technology groups — including ByteDance, Alibaba and Tencent — to buy more than 400,000 H200 chips combined, as Beijing seeks to support its ambitions in artificial intelligence while balancing efforts to bolster domestic chip production.The first round of approvals could be worth around $10 billion, with other companies still awaiting clearance. According to the Wall Street Journal, firms seeking approval were required to submit detailed explanations outlining how the chips would be used.The move comes as Nvidia chief executive Jensen Huang has been visiting China, after previously receiving approval from the Trump administration to begin H200 sales to Chinese customers. Nvidia shares rose more than 1% in extended trading following the reports.UnitedHealth Group stock priceCVS Health stock priceHumana stock priceMeta stock priceMicrosoft stock priceTesla stock priceASML Holding stock priceAT&T stock priceStarbucks stock priceGE Vernova stock priceNvidia stock price

Original: Fed Call and Earnings Wave Take Center Stage as Markets Brace for Volatility: Dow Jones, S&P, Nasdaq, Wall Street Futures

Grabar Law Office is investigating claims on behalf of shareholders of Humana Inc. (NYSE: HUM). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
If you purchased Humana Inc. (NYSE: HUM), shares prior to December July 27, 2022, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.
Please visit https://grabarlaw.com/the-latest/humana-shareholder-investigation/, contact Joshua Grabar at jgrabar @FH-6085 to learn more.

HUM

https://x.com/toobaffled/status/1837666255475823004 $HUM

Humana solid earnings this morning 10/30/20024:
7:01 AM EDT, 10/30/2024 - Humana (HUM) reported Q3 adjusted earnings Wednesday :
- $4.16 per diluted share, down from $7.78 a year earlier. Analysts polled by Capital IQ expected $3.39.
- Revenue for the quarter ended Sept. 30 was $29.40 billion, up from $26.42 billion a year earlier. Analysts surveyed by Capital IQ expected $28.65 billion.
The company said it now expects 2024 adjusted EPS to be at least $16. That compares with about $16 previously. Analysts surveyed by Capital IQ expect $16.16.

Humana on the Up & UP...
GLTA

Humana earning in 2 days!
On the Up & UP !
GLTA

2x happy now that Cigna merger talks confirmed resumed !!!
GLTA

Happy to be in HUM !
GLTA

Millions about to loose Medicaid coverage as pandemic restrictions are lifted. Google it for your due deligence, most coverages are people of color and Hispanic . Will show up in 2 nd quarter numbers

Millions about to loose Medicaid coverage as pandemic restrictions are lifted. Google it for your due deligence, most coverages are people of color and Hispanic . Will show up in 2 nd quarter numbers

Barrons journalist 9-23-2022 @ 11:33 am reposts that Citi group and Oak Street project a $14 price for buyout of Cano Health, current price 1.33.
Humana had first right of refusal looks like Humana passed. Journalist was KARISHMA Vanjani with BARRON’S.

Looks like Humana has passed on fort right of refusal to purchase Cano Health Care. CVS just announced buy Medavail MDVL, CVS states they are offering all employees jobs at CVS and retaining all prescription customers and placing all medicine inventory in local CVS stores. CVS stragically only bought assets in Cano Health Centers, this removes all Medavail Spot Rex locations out of Cano Health Centers and now CVS can close on the purchase of Cano Health after closing on Medavail first quarter. Check press release by CVS. Humana had first right of refusal.

Anticipating a bounce of 20%+ over the next 30 days...to offset one time hit from a couple of days ago!

Humana Q4 2020 Earnings Preview

Feb. 02, 2021 1:04 PM ETHumana Inc. (HUM)By: Pranav Ghumatkar, SA News Editor

Humana (NYSE:HUM) is scheduled to announce Q4 earnings results on Wednesday, February 3rd, before market open.

The consensus EPS Estimate is -$2.32 and the consensus Revenue Estimate is $18.76B (+15.1% Y/Y).

Over the last 2 years, HUM has beaten EPS estimates 100% of the time and has beaten revenue estimates 100% of the time.

Over the last 3 months, EPS estimates have seen 1 upward revision and 18 downward. Revenue estimates have seen 10 upward revisions and 4 downward.

Humana inks medicare network agreement with Grand View Health

Oct. 5, 2020 9:27 AM ET|About: Humana Inc. (HUM)|By: Khyathi Dalal, SA News Editor
Humana (NYSE:HUM) and community health system Grand View Health signed an agreement for providing in-network access for Humana Medicare Advantage members in southeast Pennsylvania at the system's Grand View Hospital and outpatient locations, and with Grand View Health physicians.

Agreement also enables in-network access to Grand View Health primary care providers and specialists.

Agreement terms were not disclosed; it is effective Nov 1, 2020.

$HUM | #Humana Inc Potential Breakout



Possible pennant breakout from ABCDE correction possible entry $407 Upside Fibonacci target $440

News: $HUM University of California, Los Angeles Wins the Humana-Mays Health Care Analytics Case Competition

The student team of Ozguk Cetinok, Leah Kelly, and Erica Millwater from the University of California, Los Angeles (UCLA) has won the $30,000 First Place prize in the Humana-Mays Health Care Analytics 2019 Case Competition sponsored by health and well-being company Humana Inc. (NYSE: HUM) an...

In case you are interested HUM - University of California, Los Angeles Wins the Humana-Mays Health Care Analytics Case Competition

When medical debt collectors decide who gets arrested - ProPublicahttps://apple.news/AQqxtc_LpSQupZE-Old3vUw

Humana $HUM Pulls Back, But More Upside Is Coming

In 2019, all of the leading managed health care stocks have been very volatile. Political pressure from both sides of the aisle have been the catalyst for the excessive whipsaw in this industry group. Stocks such as Humana Inc (NYSE:HUM), Cigna Corp (NYSE:CI), UnitedHealth Group Inc (NYSE:UNH) and others have been very susceptible to political news on a daily basis. Last week, the sector rallied sharply higher after the White House abandoned its plan to eliminate rebates from government drug plans. Unfortunately, these stocks are pulling back today after Presidential candidate Joe Biden proposes a public option for health insurance for anyone who wants it and will give power to Medicare to negotiate drug prices.

Last week, the managed health care stocks all broke out on a technical basis. Humana Inc (NYSE:HUM) is one stock that should have more upside despite today's pullback. Today, HUM stock is falling by $4.48 to $286.77 a share. Traders and investors should now watch and see if this stock can consolidate on the charts as last week's break-out pattern suggests a move back up to the $310.00 level. This major resistance level is where the stock sold off in late February 2019. I will be be keeping this leading heath care stock on my radar for a bullish pattern development.





Nick Santiago
InTheMoneyStocks

Health Insurance Stocks Tumble, Watch This Trade Level $HUM

Today, most of the leading health insurance stock are falling sharply lower. Leaders in the industry group such as Humana Inc (NYSE:HUM), WellCare Health Plans Inc (NYSE:WCG), United Health Group (NYSE:UNH) and others are all trading in negative territory. A couple days ago, a Federal judge voiced concerns over the DOJ's approval of CVS/Aetna merger. This news is the likely catalyst for the big decline in the sector.

Humana Inc(NYSE:HUM) is a leading stock in the health insurance group that is trading lower by $14.76 to $309.71 a share. This stock is now testing it's 200-day moving average. Should this stock close below this key moving average it would indicate lower prices ahead. The next major support area that looks attractive for HUM stock will be around the $290.00 level. This is where the stock broke out in May 2018 and should be very solid chart support when retested.





Nick Santiago
InTheMoneyStocks

LOL buy hold. Simple!!

STOP the Aetna-Humana merger/sale! Thousands of Humana employees will lose their jobs and there will be a monopoly on Medicare in many states! This merger is all about money $$$$$ and Humana executives are banking on making MILLIONS from it even if it means leaving THOUSANDS jobless. Senior citizens in many states will have little to no choice on Medicare plans.

Please click here and sign the "Stop the Aetna-Humana Healthcare Merger/Sale" petition and stop the greed!

Humana ($HUM) reported in line fourth quarter adjusted earnings per share, while its first quarter guidance is below estimates.

Aetna Beats By $0.15, Reports Revenues In-Line - article discusses Humana http://marketexclusivecom/aetna-aet-beats-by-0-15-reports-revenues-in-line/2196/

Sell short or buy put's as we head to $135. After earnings it will move quick